Download Wake Forest University Health Sciences

APPENDIX X
WAKE FOREST UNIVERSITY HEALTH SCIENCES
CLINICAL CARDIOLOGY / CLINICAL CARDIOVASCULAR
RESEARCH TRAINING PROGRAM
CURRICULUM VITAE
Director T32 Program: David M. Herrington, MD, MHS
Wake Forest University Health Sciences
Department Of Internal Medicine / Section on Cardiology
Medical Center Blvd. Winston-Salem, NC 27157
[email protected] 336-716-4950
Sponsor: NIH/NHLBI T32 CVD Epidemiology Training Program
OBJECTIVE:
The purpose of the CVD Epidemiology Training Program, a federally-funded National Research
Service Award (NRSA) Institutional Research Training Grant (2 T32 HL076132), is to attract and train
a cohort of outstanding physician scientists who will be fluent in the latest developments in
cardiovascular disease and able to apply this knowledge to the conduct of new cardiovascular
epidemiology and clinical cardiovascular research. Key features of the training program include
completion of a Masters Degree in Clinical and Population Translational Science with a curriculum
that also includes formal training in molecular biology and genetics, supplemental training in
genomics, proteomics and informatics, joint mentorship with both clinical and basic science faculty,
and participation in external NHLBI sponsored short courses in cardiovascular epidemiology, and the
genetics of complex heart, lung, and blood disorders.
CURRENT TRAINEES:
1. Dr. Shivani Aggarwal – appointed 7/1/2013
Current: Wake Forest University, MS, Clinical and Population Translational Science
MBBS, Adichunchanagiri Institute of Medical Sciences, India, 2007
2. Dr. Waqas Quershi – appointed 7/1/2013
Current: Wake Forest University, MS, Clinical and Population Translational Science
MBBS, Rawalpindi Medical College, Pakistan, 2007
PAST TRAINEES:
3. Dr. Michael Cammarata – appointed 7/1/2012-6/30/2014
Current: Wake Forest University, MS, Clinical and Population Translational Science
Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2013
MD, University of Florida College of Medicine, 2008
4. Dr. Ashleigh Owen – appointed 7/1/2012-6/30/3014
Current: Wake Forest University, MS, Clinical and Population Translational Science
Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2013
MD, Medical University of South Carolina College of Medicine, 2009
5. Dr. Robert Riley – appointed 7/1/2011-6/30/2013
Current: Clinical Cardiology Fellow, Internal Medicine/ Cardiology, Wake Forest University, 2012
MS, Clinical and Population Translational Science, Wake Forest University, 2013
Thesis: The Development and Implementation of Secondary Prevention Measures for Coronary Artery
Disease
MD, University of Virginia, 2008
6. Dr. Farah Dawood - appointed 7/1/2011-6/30-2013
Current: Wake Forest University, MS, Clinical and Populational Translational Science
Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012
MD, Virginia Commonwealth University, 2008
7. Dr. Amir Azeem – appointed 7/1/2011-6/30/2013
Current: Clinical Cardiology Fellow, University of Mississippi, Jackson, MS
MS, Clinical and Population Translational Science, Wake Forest University, 2013
Thesis: Hemoglobin A1C and Prediction of Cardiovascular Disease and All-Cause Mortality
MBBS, Dow Medical College, Karachi, Pakistan, 1999
8. Dr. Matthew Sellers – appointed 7/1/2010-6/30/2012
Current: Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2014
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2011-2014
MS, Clinical and Population Translational Science, Wake Forest University, 2013
Thesis: Replication and Functional Validation of SNPs Previously Associated with Coronary Artery
Disease.
MD, Medical University of South Carolina College of Medicine, 2007.
9. Dr. Pelbreton Balfour – appointed 7/1/2010-6/30-2012
Current: Research Assistant, Division of Public Health Sciences, Wake Forest University, 2014
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2011-2014
MS, Clinical and Population Translational Science, Wake Forest University, 2014
Thesis: Amino-Terminal Pro-Brain Natriuretic Peptide, Diabetes, And Incident Heart Failure: The
Multi-Ethnic Study Of Atherosclerosis
MD, University of Pittsburgh School of Medicine, 2006.
10. Dr. Jennifer Anderson – appointed 7/1/2009-6/30-2011
Current: Cardiologist, St. Alphonsus Medical Center, Boise Idaho
Clinical Cardiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2010-13
MD, University of Washington – Seattle, Washington, 2006.
PhD, University of Washington – Seattle, Washington, 2002.
MS, Clinical and Populational Translational Science, Wake Forest University, 2011
Thesis: Sex Differences in the relationship of Polyunsaturated Fatty Acids and Noninvasive Imaging
Measure of Subclinical Cardiovascular Disease.
11. Dr. Subhashish Agarwal – appointed 7/1/2009-6/30/2011
Current: Electrophysiology Fellow, Oakwood Hospital & Medical Center Cardiology
Fellowship Program, Dearborn, MI, 2014
Clinical Cardiology Fellow, Oakwood Hospital & Medical Center Cardiology
Fellowship Program, Dearborn, MI, 2011-2014
MS, Clinical and Populational Translational Science, Wake Forest University, 2011
Thesis: Metabolic Syndrome derived from Principal Component Analysis and Predication of Incident
Cardiovascular Events Multi Ethnic Study of Atherosclerosis (MESA)
MBBS, University of Mumbai, Mumbai, India, 1997.
12. Dr. Peter Matthew Belford – appointed 7/1/2008-6/30/2010
Current: Assistant Professor, Internal Medicine/Cardiology, Wake Forest University, 2014
Cardiologist, Morehead Hospital, Eden, NC, 2012
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2009-2012
MD, Wake Forest University, 2004.
13. Dr. Manish Jain – appointed 7/1/2008-6/30/2010
Current: Cardiologist/Electrophysiologist, South Carolina Heart Center, Columbia, SC
Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest
University, 2009-2012
MS, Clinical & Population Translational Science, Wake Forest University, 2011
Thesis: Association of Visceral Adipose Tissue (VAT) with Pulse Pressure (PP) in the Multi Ethnic
Study of Atherosclerosis.
MD, University of Texas-South Western, 2004.
14. Dr. Sidharth Shah – appointed 7/1/2007-6/30/2009
Current: Cardiologist, Wake Heart and Vascular, Raleigh, NC
Electrophysiology Fellow, Internal Medicine/Cardiology, Wake Forest University, 2012
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2008-2011
MS-Wake Forest University, MS, Health Services Research, 2010
Thesis: Genetic Variants in NOS1AP and the QT Interval
MD, University of Kansas – Kansas City, 2004.
15. Dr. Brandon Stacey – appointed 7/1/2007-6/30/2009
Current: Assistant Professor, Internal Medicine/Cardiology, Wake Forest University
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2008-2011
MS- Wake Forest University, MS, Health Services Research, 2009
Thesis: Modification of the Effect of Glycemic Status on Aortic Distensibility by Age in the
Multi-Ethnic Study of Atherosclerosis
MD, University of South Alabama College of Medicine – Mobile, 2004.
16.Dr. Stewart Allen– appointed 7/1/2006-6/30/2008
Current: Cardiologist, St. Helena Cardiology, St. Helena, CA
Interventional Fellow, Internal Medicine/Cardiology, Wake Forest University, 2011
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2007-2010
MS-Wake Forest University, MS, Health Services Research, 2009
Thesis: The Association of Selective and Nonselective Nonsteroidal Antiinflammatory Medications
with Reverse Endothelial Function and Indices of Thrombosis in the Multi-Ethnic Study Of
Atherosclerosis
MD, Wake Forest University, 2001.
17. Dr. Darryl Prime– appointed 7/1/2006-6/30/2007
Current: Cardiologist, Gadsden Regional Medical Center, Gadsden, AL
Interventional Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2010-2011
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2007-2010
MS- Health Services Research, Wake Forest University, 2008
Thesis: The Utility of Pulse Pressure Measured by Radial Arterial Tonometry in Determining
Cardiovascular Disease in Adults
MD, University of Alabama - Birmingham, 2002.
18. Dr. Kurt Daniel – appointed 7/1/2005 – 6/30/2007
Current: Cardiologist, Carolina Cardiology Associates, High Point, NC
Interventional Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2009
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2006-2009
MS-Health Services Research, Wake Forest University, 2007
Thesis: Genetic Variations in the ATP-Binding Cassette Gene are Associated with Altered Levels of
Markers of Systemic Inflammation
DO, Oklahoma State University, 2001.
19. Dr. Jerry John– appointed 7/1/2005 – 6/30/2007
Current: Co-Director, Heart Failure Prevention and Treatment Program, McKay-Dee Hospital Center
/ Intermountain Health Care, Ogden, UT
Wake Forest University, MS, Health Services Research, 2007
Thesis: Response to Postural Change in Diastolic Heart Failure: Decreased Left Thesis: Ventricular
Compliance Contributes to Reductions in Stroke Volume and Cardiac Output
MD, Michigan State University, 2001.
20. Dr. Joseph Yeboah– appointed 7/1/2005 – 6/30/2007
Current: Assistant Professor, Internal Medicine, Section on Cardiology,
Wake Forest University, 2011
Fellow, Clinical Cardiology, University of Virginia, 2008-2011
Wake Forest University, MS, Health Services Research, 2007
Thesis: Predictive Value of Endothelial Dysfunction for Incident Cardiovascular Events in the CHS
Cohort
MD, Yale University, 2005.
21. Dr. Phillip Mellen - appointed 7/1/2004 – 6/30/2006
Current: Internist, Hattiesburg Clinic’s Hypertension Center of Excellence
MS-Health Services Research, Wake Forest University, 2006
Thesis: Whole Grain Intake and Progression of Carotid Atherosclerosis in a Multi-Ethnic Cohort: The
Insulin Resistance Atherosclerosis Study
MD – University of Mississippi, 2001.
22. Dr. Susan Lakoski – appointed 7/1/2004 – 6/30/2005
Current: Assistant Professor of Medicine. University of Vermont College of Medicine
Assistant Professor Cardiology, University of Texas, 2008-2013
Clinical Cardiology Fellow, Internal Medicine, Section on Cardiology, Wake Forest University,
2005-2008
MS-Health Services Research, Wake Forest University, 2005
Thesis: The Relationship Between Blood Pressure and C-Reactive Protein in the Multi-Ethnic Study of
Atherosclerosis (MESA)
MD – University of Texas, 2000.
EDUCATIONAL REQUIREMENTS OF THE CVD EPIDEMIOLOGY TRAINING
PROGRAM:
Masters Degree Clinical and Population Translational Sciences, Wake Forest University
AHA’s 10 day Seminar on the Epidemiology and Prevention of Cardiovascular Disease
AHA’s Annual Conference on Cardiovasular Disease Epidemiology and Prevention in Association
w/the Council on Nutrition, Physical Activity and Metabolism.
Faculty Development Program
Ethics in Science course offered through Grad school
The Collaborative IRB Training Initiative (CITI)
The Human Research Subject Protection Certification Program and HIPPA Compliance training
courses.
NIH online course on responsible conduct of research.
AWARDS AND HONORS:
Dr. Susan Lakoski, NIH Loan Repayment Award, 2004.
Dr. Kurt Daniel, NIH Loan Repayment Award, 2005.
Dr. Susan Lakoski, Sandra Daugherty Award for Excellence in Cardiovascular Disease and
Hypertension Epidemiology. 45th Annual Conference on Cardiovascular Disease Epidemiology and
Prevention, April 2005.
Dr. Kurt Daniel, Travel award from GSK Research & Education Foundation for CVD to attend the
New Frontiers in Genomics and Cardiovascular Disease Conference in Philadelphia, April 2005.
Dr. Kurt Daniel, Henry I Russek Travel Award to attend the 37th Annual Cardiovascular
Symposium from the American College of Cardiology, December 2005.
Dr. Darryl Prime, Travel Award to attend the AHA’s 43th 10-Day Seminar on the Epidemiology and
Prevention of Cardiovascular Disease, 2008
Dr. Susan Lakoski, Women in Cardiology Trainee Award for Excellence , American Heart
Association’s Scientific Sessions 2006, November 12- November 15, 2006.
Dr. R. Brandon Stacey, NIH Loan Repayment Award, 2007
Dr. Stewart Allen, American Heart Association Spotlight Series Speaker, 2007
Dr. Jerry John, First Place – Oral Abstract Presentation , The Determinants of Exercise
Intolerance in Diastolic Heart Failure Patients, Ohio Chapter American College of Cardiology, 2007
Dr. P. Matthew Belford, NIH Loan Repayment Award, 2008
Dr. P. Matthew Belford, Travel Award to attend the AHA’s 43th 10-Day Seminar on the
Epidemiology and Prevention of Cardiovascular Disease, 2008
Dr. Joseph Yeboah, Finalist, Elizabeth Barrett-Connor Research Award for Young Investigators in
Training, 2008
Dr. Sidharth Shah, Fellow Basic Research Silver Award Third Annual Internal Medicine Resident
and Fellow Research Day April 2009. Poster presentation of: Shah SA, Herrington DM, Howard TD,
Burke GL, Kao WH, Guo X, Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich
SS, Bowden DW, and Post W. Associations Between Genetic Variations in NOSIAP and QT Interval
Duration in Four Racial/Ethnic Groups in the Multi-Ethnic Study of Atherosclerosis (MESA).
Dr. Sidharth Shah, A.M. Nomeir Award for Excellence in Echocardiography, July 2009.
Dr. Sidharth Shah, Note of Appreciation, 3rd year Medical Students of Wake Forest University
School of Medicine- Internal Medicine Rotation. December 2010.
Dr. Jennifer Anderson, Finalist, Elizabeth Barrett-Connor Research Award for Young Investigators in
Training, 2010
Dr. Susan Lakoski, Endocrine Society International Award for Excellence in Published Clinical
Research, 2012
Dr. Robert Riley, First Place Award (Gold Award), Wake Forest University School of Medicine
Resident/Fellows Research Day, “Guideline-Based Treatment of Anemic STEMI Patients: A Report
from the ACTION Registry® - GWTGTM”, May 8, 2012.
Dr. Pelbreton Balfour, Second Place Award, Wake Forest University School of Medicine
Resident/Fellows Research Day,” The Association between Amino Terminal Pro-Brain Natriuretic
Peptide and Incident Heart Failure in Diabetes- The Multi Ethnic Study of Atherosclerosis”, May 8,
2012.
Dr. Susan Lakoski, International Award for Excellence in Published Clinical Research, Endocrine
Society, Journal of Clinical Endocrinology and Metabolism, 2012.
Dr. Amir Azeem, Fellow of American College of Physicians (FACP), Sept 2012.
Dr. Pelbreton Balfour, Clinical Cardiology Minority Travel Grant Award, 2013 AHA Scientific
Sessions.
Dr. Joesph Yeboah, NHLBI-MESA Young Investigator Award 2013.
Dr. Waqas Qureshi, Reviewer, Annals of Internal Medicine 2013.
Dr. Pelbreton Balfour, Second Place Award, Wake Forest School of Medicine Eighth Annual
Research Day, “Clinical Determinants of Global Left Ventricular Systolic Function by Cardiac
Magnetic Resonance Imaging: The Jackson Heart Study”, May 2014.
Dr. Waqas Quershi, AHA Top 10% Abstracts , “Metabolomic Features Associated With Incident
Hypertension - Results From Insulin Resistance Atherosclerosis Study,” Best of AHA Speciality
Conference AHA Scientific Sessions, Nov 2014.
Dr. Joseph Yeboah, Harold Amos Faculty Development Award Competition Finalist, 2014
Dr. Brandon Stacey, Excellence in Teaching Recognition, Internal Medicine Residency Program,
Wake Forest University School of Medicine, 2014
Dr. Brandon Stacey, Tinsley Harrison Research Scholar Mentor Award, 2014
Dr. Brandon Stacey, Cardiovascular Medicine Outstanding Teaching Award for Non-Invasive CV
Medicine, August 2014.
Dr. Jerry John, Gold Achievement Award - AHA 2014.
Dr. Jerry John, Mckay-Dee Award for 3rd Lowest Heart Failure Readmission Rate in Country –
CMS, 2014.
GRANTS:
Funded:
Dr. Susan Lakoski, PI, The Association Between Interleukin-1 Receptor Associated Kinases
(IRAK1) Genetic Variants and IL-10 levels in the ERA Study. Funded by the Wake Forest University
Center for Public Health Genomics, June 2005.
Dr. Philip Mellen, Co-I, “Dietary Fats, Genetic Variation, and Progression of Coronary
Atherosclerosis Among Women” 2005.
Dr. Philip Mellen, PI, “Serum Uric Acid and Incident Metabolic Syndrome in the Atherosclerosis
Risk in Communities Cohort” 2004-2006
Dr. Philip Mellen, Co-I, “Effect of Muscadine Grapeseed Extract on Endothelial Function” (Natures
Pearl, Inc.) 2006-2007.
Dr. Susan Lakoski (PI) “Cardiorespiratory Fitness and Healthy Aging: The Cooper Reunion” The
Cooper Institute – Foundation Grant ; Project Period: 7/1/2009-6/30/11
Dr. Jerry John (Co-I) “LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure
Therapy) 2011-present.
Dr. Joseph Yeboah, Robert M. Berne Cardiovascular Research Center Training Grant, University of
Virginia (5T32-HL007284 / Dr. Brain Duling, Program Director ). July 2010 – June 2012.
Dr. Joseph Yeboah (Co-I), “Longitudinal Changes in Pericardial Adiposity and Subclinical
Atherosclerosis” R01 HL 098445 Project Period: 08/01/2010-03/31/2014
Dr. Brandon Stacey (Co-I), “Atherosclerosis Risk in Communities (ARIC) Study – Field Centers”
HHSN268201100007C (Wagenknetcht); Project Period: 11/15/2010–1/14/2016.
Dr. Matt Sellers and David Herrington. Epigenetic Analysis of Lipid Phenotypes in Liver Tissue
from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study TSI Pilot Funding
Program. 4-1-2011 to 3-31-2012.
Dr. Joseph Yeboah (Co-I), “Preventing Anthracycline Cardiovascular Toxicity with Statins”
R01HL118740-01; Project Period: 04/01/2013 – 03/31/2018
Dr. Joseph Yeboah (Co-I), “Multi-Ethnic Study of Atherosclerosis - Field Center” N01-HC-95165;
Funding: Jan 2014-8/14/2015
Dr. Joseph Yeboah (Co-I), “Systolic Blood Pressure Intervention Trial (SPRINT)”
HHSN268200900048C; Project Period: 09/14/09 – 09/13/18
Dr. Robert Riley,PI “Are serial electrocardiograms Additive to serial second-generations troponins in
Predicting acute coronary Syndromes in patients with undifferentiated chest pain (ASAP CATH)
Study” Wake Forest University Baptist Medical Center Initiative for Healthcare Delivery Innovation
Project Application. Project Period: 7/1/13-6/30/14
Dr. Robert Riley,PI AHA/ MAA Winter 2013 Clinical Research Program
“Are Serial ECGs Additive to Novel Serial Troponins in Predicting ACS in Patients with
Undifferentiated Chest Pain Study”Project Period: 7/1/13-6/30/15
Dr. Susan Lakoski (PI) Centers of Biomedical Research Excellence (P20GM103644-01A1) Project 5
Title: “Behaviors, Chronic Disease, and Quality of Life After Ductal Carcinoma in Situ” Project
Period: 8/1/13- 6/30/18
.
Dr. Susan Lakoski (PI) REACH Institutional Grant Program – University of Vermont
Title: “An Exercise Training and Behavior Weight Loss Program after an Acute Blood Clot: TRAIN
ABC” Project Period: 6/1/2013-6/30/14
Dr. Susan Lakoski (PI) University of Vermont School of Medicine
Title: “Exercise Training for the Prevention of Cancer Thrombosis: the EXPECT Pilot Trial” Project
Period: 4/1/2012-6/30/15
Dr. Susan Lakoski (Co-I) University of Vermont School of Medicine
Title: “Predictors of Dyspnea/Fatigue Syndrome in Breast Cancer Survivors Before and After an
Exercise Intervention” Project Period: 7/12 - present
Dr. Pelbreton Balfour, PI, Investigator Research Supplement (IRS) to the NHLBI for a supplement
which promotes diversity in health-related research. The parent grant is Epidemiologic Determinant
of Cardiac Structure and Function Among Hispanics (R01 HL104199; Carlos J. Rodriguez, PI).
Project Period: 7/1/13-6/30/15
Dr. Brandon Stacey, Co-I, “Pre-Determine Study” Project Period: 2014-present.
Dr. Amir Azeem, Co-I “Association between Glycemic Status and Cardiac MRI Measures of
Myocardial Structure and Function in African Americans – Jackson Heart Study” Project Period:
2014-present.
BIBLIOGRAPHY:
Journal Articles
1. Bonds DE, Palla S, Bertoni AG, Mellen P, Goff DC. Hypertension treatment in the ambulatory
setting: comparison by race and gender in a national survey. J Clin Hypertens (Greenwich).
2004;6(5):223-8; quiz 9-30.
2. Herrington DM, Lakoski SG. Chest Pain in Postmenopausal Women on Hormone Therapy.
American College of Cardiology Foundation and Elseiver, Inc.; 2004 [updated 2004; cited];
Cardiosource Web Site]. Available from.
3. Mellen PB, Palla SL, Goff DC, Jr., Bonds DE. Prevalence of nutrition and exercise counseling for
patients with hypertension. United States, 1999 to 2000. J Gen Intern Med. 2004;19(9):917-24.
PMCID: 1492516.
4. Lakoski SG, Brosnihan B, Herrington DM. Hormone therapy, C-reactive protein, and progression
of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery
Atherosclerosis (ERA) trial. Am Heart J. 2005;150(5):907-11.
5. Lakoski SG, Cushman M, Palmas W, Blumenthal R, D'Agostino RB, Jr., Herrington DM. The
relationship between blood pressure and C-reactive protein in the Multi-Ethnic Study of
Atherosclerosis (MESA). J Am Coll Cardiol. 2005;46(10):1869-74.
6. Lakoski SG, Herrington DM. Effects of hormone therapy on C-reactive protein and IL-6 in
postmenopausal women: a review article. Climacteric. 2005;8(4):317-26.
7. Lakoski SG, Herrington DM. Effects of oestrogen receptor-active compounds on lipid metabolism.
Diabetes Obes Metab. 2005;7(5):471-7.
8. Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive
treatment. J Hypertens. 2005;23(7):1311-25.
9. John JM, Herrington DM. Maintenance warfarin dose varies according to two haplotypes of the
vitamin K epoxide reductase gene. Future Cardiol. 2006;2(1):29-32.
10. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB, Jr., Herrington
DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA)
cohort. Am Heart J. 2006;152(3):593-8.
11. Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein concentration and
incident hypertension in young adults: the CARDIA study. Arch Intern Med. 2006;166(3):345-9.
12. Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, Wofford MR,
Herrington DM. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis
risk in communities study. Hypertension. 2006;48(6):1037-42.
13. Mellen PB, Cefalu WT, Herrington DM. Diabetes, the metabolic syndrome, and angiographic
progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol.
2006;26(1):189-93.
14. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Heart Fail Clin. 2007;3(4):437-53.
15. Kitzman DW, Daniel KR. Diastolic heart failure in the elderly. Clin Geriatr Med.
2007;23(1):83-106.
16. Lakoski SG, Cushman M, Blumenthal RS, Kronmal R, Arnett D, D'Agostino RB, Jr., Detrano RC,
Herrington DM. Implications of C-reactive protein or coronary artery calcium score as an adjunct to
global risk assessment for primary prevention of CHD. Atherosclerosis. 2007;193(2):401-7.
17. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K,
Blumenthal RS. Coronary artery calcium scores and risk for cardiovascular events in women classified
as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch
Intern Med. 2007;167(22):2437-42.
18. Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB, Xu J, Bowden DW,
Herrington DM. The association between innate immunity gene (IRAK1) and C-reactive protein in the
Diabetes Heart Study. Exp Mol Pathol. 2007;82(3):280-3. PMCID: 1995105.
19. Mellen PB, Bittner V, Herrington DM. Post-challenge glucose predicts coronary atherosclerotic
progression in non-diabetic, post-menopausal women. Diabet Med. 2007;24(10):1156-9.
20. Mellen PB, Bleyer AJ, Herrington DM. Response to Treatment of Hyperuricemia in Essential
Hypertension. Hypertension. 2007.
21. Mellen PB, Goff DC, Jr. Nonpharmacological treatment of hypertension: impact on prevalence
estimates. Hypertension. 2007;50(1):e1; author reply e2.
22. Mellen PB, Liese AD, Tooze JA, Vitolins MZ, Wagenknecht LE, Herrington DM. Whole-grain
intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis
Study. Am J Clin Nutr. 2007;85(6):1495-502.
23. Prime DD, Brosnihan KB, Herrington DM. Effects of hormone therapy on blood pressure and the
renin-angiotensin system in postmenopausal women. Minerva Cardioangiol. 2007;55(4):477-85.
24. Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Wescott C, Assimos D, Stratta R,
Adams P, Hartmann E. Impact of ethnicity on living kidney donation. American Journal of
Transplantation. 2007;7:274.
25. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation
predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation.
2007;115(18):2390-7.
26. Yeboah J, Reboussin DM, Waters D, Kowalchuk G, Herrington DM. Effects of estrogen
replacement with and without medroxyprogesterone acetate on brachial
flow-mediated vasodilator responses in postmenopausal women with coronary artery disease. Am
Heart J. 2007;153(3):439-44.
27. Yeboah J, Sane DC, Crouse JR, Herrington DM, Bowden DW. Low plasma levels of FGF-2 and
PDGF-BB are associated with cardiovascular events in type II diabetes mellitus (diabetes heart study).
Dis Markers. 2007;23(3):173-8.
28. Daniel KR, Bertoni AG, Ding J, Johnston S, Budoff MJ, Bluemke DA, Carr JJ. Comparison of
methods to measure heart size using noncontrast-enhanced computed tomography: correlation with left
ventricular mass. J Comput Assist Tomogr. 2008;32(6):934-41.
29. Lai TS, Liu Y, Tucker T, Daniel KR, Sane DC, Toone E, Burke JR, Strittmatter WJ, Greenberg
CS. Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug
libraries. Chem Biol. 2008;15(9):969-78. PMCID: 2637080.
30. Lakoski SG, Liu Y, Brosnihan KB, Herrington DM. Interleukin-10 concentration and coronary
heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.
Atherosclerosis. 2008;197(1):443-7. PMCID: 2279176.
31. Lehtinen AB, Newton-Cheh C, Ziegler JT, Langefeld CD, Freedman BI, Daniel KR, Herrington
DM, Bowden DW. Association of NOS1AP genetic variants with QT interval duration in families from
the Diabetes Heart Study. Diabetes. 2008;57(4):1108-14.
32. McKimmie RL, Daniel KR, Carr JJ, Bowden DW, Freedman BI, Register TC, Hsu FC, Lohman
KK, Weinberg RB, Wagenknecht LE. Hepatic steatosis and subclinical cardiovascular disease in a
cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol.
2008;103(12):3029-35.
33. Mellen PB, Gao SK, Vitolins MZ, Goff DC, Jr. Deteriorating dietary habits among adults with
hypertension: DASH dietary accordance, NHANES 1988-1994 and 1999-2004. Arch Intern Med.
2008;168(3):308-14.
34. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a
meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18(4):283-90.
35. Nelson MR, Daniel KR, Carr JJ, Freedman BI, Prineas RJ, Bowden DW, Herrington DM.
Associations between electrocardiographic interval durations and coronary artery calcium scores: the
Diabetes Heart Study. Pacing Clin Electrophysiol. 2008;31(3):314-21.
36. Shah SA. Case: 23 year-old with recurrent seizures (Bechet’s Disease). Medicine/Pediatrics
Case-Based Review: McGraw-Hill Specialty Board Review; 2008.
37. Shah SA. Case: 59 year-old with ”ST- Elevation MI” (Takotsubo cardiomyopathy).
Medicine/Pediatrics Case-Based Review: McGraw-Hill Specialty Board Review; 2008.
38. Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated
dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study.
Atherosclerosis. 2008;197(2):840-5.
39. Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM. Effects of hormone therapy on
soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Menopause.
2008;15(6):1060-4.
40. Yeboah J, Sutton-Tyrrell K, McBurnie MA, Burke GL, Herrington DM, Crouse JR. Association
between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the
cardiovascular health study. Atherosclerosis. 2008;197(2):768-76.
41. Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G. Implications of
increased C-reactive protein for cardiovascular risk stratification in black and white men and women in
the US. Clin Chem. 2009;55(9):1627-36. PMCID: 2810186.
42. Daniel KR, Wells G, Stewart K, Moore B, Kitzman DW. Effect of aldosterone antagonism on
exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart
failure. Congest Heart Fail. 2009;15(2):68-74. PMCID: 2922000.
43. Duprez DA, Jacobs DR, Jr., Lutsey PL, Herrington D, Prime D, Ouyang P, Barr RG, Bluemke DA.
Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of
atherosclerosis (MESA). Ethn Dis. 2009;19(3):243-50. PMCID: 2924814.
44. Hall WB, Truitt SG, Scheunemann LP, Shah SA, Rivera MP, Parker LA, Carson SS. The
prevalence of clinically relevant incidental findings on chest computed tomographic angiograms
ordered to diagnose pulmonary embolism. Arch Intern Med. 2009;169(21):1961-5.
45. Kanjwal Y, John JM, Burket MW. Passing sheaths and electrode catheters through inferior vena
cava filters: safer than we think? Catheter Cardiovasc Interv. 2009;74(6):966-9.
46. Lakoski SG, Lagace TA, Cohen JC, Horton JD, Hobbs HH. Genetic and metabolic determinants of
plasma PCSK9 levels. J Clin Endocrinol Metab. 2009;94(7):2537-43. PMCID: 2708952.
47. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher
MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in
patients with myocardial infarction. Am Heart J. 2009;157(4):688-94.
48. Lehtinen AB, Daniel KR, Shah SA, Nelson MR, Ziegler JT, Freedman BI, Carr JJ, Herrington
DM, Langefeld CD, Bowden DW. Relationship between genetic variants in myocardial sodium and
potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. Ann
Noninvasive Electrocardiol. 2009;14(1):72-9.
49. Minton JA, Tofade TS, Shah SA. Psychosis from Anticholinergic Medications Administered at a
Smoking Cessation Clinic. Journal of Pharmacy Practice. 2009;22(October 2009):489-93.
50. Reeves-Daniel A, Freedman BI, Assimos D, Hartmann EL, Bleyer A, Adams PL, Westcott C,
Stratta RJ, Rogers J, Farney AC, Daniel KR. Short-term renal outcomes in African American and
Caucasian donors following live kidney donation. Clin Transplant. 2009.
51. Rudock ME, Liu Y, Ziegler JT, Allen SG, Lehtinen AB, Freedman BI, Carr JJ, Langefeld CD,
Bowden DW. Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid
calcium in the Diabetes Heart Study. Atherosclerosis. 2009;203(2):459-65. PMCID: 2699582.
52. Yeboah J. Commentaries on viewpoint: pick your Poiseuille: normalizing the shear stimulus in
studies of flow-mediated dilation. J Appl Physiol. 2009;107(4):1360; author reply 6.
53. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington
DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a
population-based study: the multi-ethnic study of atherosclerosis. Circulation. 2009;120(6):502-9.
PMCID: 2740975.
54. Anderson JS, Nettleton JA, Herrington DM, Johnson WC, Tsai MY, Siscovick D. Relation of
omega-3 fatty acid and dietary fish intake with brachial artery flow-mediated vasodilation in the
Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2010;92(5):1204-13. PMCID: 2954452.
55. Bowden DW, Cox AJ, Freedman BI, Hugenschimdt CE, Wagenknecht LE, Herrington D, Agarwal
S, Register TD, Maldjian JA, Ng MC, Hsu FC, Langefeld CD, Williamson JD, Carr JJ. Review of the
Diabetes Heart Study (DHS) Family of Studies: A Comprehensively Examined Sample for Genetic and
Epidemiological Studies of Type 2 Diabetes and its Complications. Rev Diabet Stud.
2010;7(3):188-201.
56. Chen J, Das S, Barlow CE, Grundy S, Lakoski SG. Fitness, fatness, and systolic blood pressure:
data from the Cooper Center Longitudinal Study. Am Heart J. 2010;160(1):166-70.
57. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C,
Hundley WG. Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly
Individuals at Risk for Cardiovascular Events. Hypertension. 2010;56(5):901-6.
58. Cushman M, McClure LA, Lakoski SG, Jenny NS. Eligibility for statin therapy by the JUPITER
trial criteria and subsequent mortality. Am J Cardiol. 2010;105(1):77-81. PMCID: 2813463.
59. Doran AC, Lehtinen AB, Meller N, Lipinski MJ, Slayton RP, Oldham SN, Skaflen MD, Yeboah J,
Rich SS, Bowden DW, McNamara CA. Id3 is a novel atheroprotective factor containing a functionally
significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ
Res. 2010;106(7):1303-11. PMCID: 2860382.
60. Fu Q, Vangundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD.
Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol.
2010;55(25):2858-68. PMCID: 2914315.
61. Jeevanantham V, Ntim W, Navaneethan SD, Shah S, Johnson AC, Hall B, Shah A, Hundley WG,
Daubert JP, Fitzgerald D. Meta-analysis of the effect of radiofrequency catheter ablation on left atrial
size, volumes and function in patients with atrial fibrillation. Am J Cardiol. 2010;105(9):1317-26.
62. John JM, Haykowsky M, Brubaker P, Stewart K, Kitzman DW. Decreased left ventricular
distensibility in response to postural change in older patients with heart failure and preserved ejection
fraction. Am J Physiol Heart Circ Physiol. 2010;299(3):H883-9. PMCID: 2944493.
63. John JM, Hussein A, Imran N, Durham SJ, Grubb BP, Kanjwal Y. Underutilization of implantable
cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction.
Pacing Clin Electrophysiol. 2010;33(6):727-33.
64. Lakoski SG, Cushman M, Siscovick DS, Blumenthal RS, Palmas W, Burke G, Herrington DM.
The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of
Atherosclerosis (MESA). J Hum Hypertens. 2010.
65. Lakoski SG, Xu F, Vega GL, Grundy SM, Chandalia M, Lam C, Lowe RS, Stepanavage ME,
Musliner TA, Cohen JC, Hobbs HH. Indices of cholesterol metabolism and relative responsiveness to
ezetimibe and simvastatin. J Clin Endocrinol Metab. 2010;95(2):800-9.
66. Liese AD, Nichols M, Hodo D, Mellen PB, Schulz M, Goff DC, D'Agostino RB. Food intake
patterns associated with carotid artery atherosclerosis in the Insulin Resistance Atherosclerosis Study.
Br J Nutr. 2010;103(10):1471-9.
67. Mellen PB, Daniel KR, Brosnihan KB, Hansen KJ, Herrington DM. Effect of muscadine grape
seed supplementation on vascular function in subjects with or at risk for cardiovascular disease: a
randomized crossover trial. J Am Coll Nutr. 2010;29(5):469-75.
68. Nettleton JA, McKeown NM, Kanoni S, Lemaitre RN, Hivert MF, Ngwa J, van Rooij FJ, Sonestedt
E, Wojczynski MK, Ye Z, Tanaka T, Anderson J. Interactions of dietary whole-grain intake with
fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of
14 cohort studies. Diabetes Care. 2010;33(12):2684-91. PMCID: 2992213.
69. Stacey RB, Bertoni AG, Eng J, Bluemke DA, Hundley WG, Herrington D. Modification of the
effect of glycemic status on aortic distensibility by age in the multi-ethnic study of atherosclerosis.
Hypertension. 2010;55(1):26-32.
70. Yeboah J, Akosah K, Ailawadi G. Heart failure due to coronary fistulas from the right and left
coronary circulation into the right atrium. J Cardiovasc Med (Hagerstown). 2010;11(7):517-8.
71. Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL, Herrington DM. Endothelial
dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population
(MESA). J Hum Hypertens. 2010.
72. Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, Shea S. Association of
plasma sphingomyelin levels and incident coronary heart disease events in an adult population:
Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(3):628-33. PMCID:
2862629.
73. Agarwal S, Morgan T, Herrington DM, Xu J, Cox AJ, Freedman BI, Carr JJ, Bowden DW.
Coronary Calcium Score and Prediction of All-Cause Mortality in Diabetes. Diabetes Care.
2011;34(5):1219-24.
74. Agarwal S, Shlipak MG, Kramer H, Jain A, Herrington DM. The association of chronic kidney
disease and metabolic syndrome with incident cardiovascular events: multiethnic study of
atherosclerosis. Cardiol Res Pract. 2011;2012:806102. PMCID: PMC3154776.
75. Agarwal S, Thohan V, Shlipak MG, Lima J, Bluemke DA, Siscovick D, Gomes A, Herrington
DM. Association between Cystatin C and MRI Measures of Left Ventricular Structure and Function:
Multi-Ethnic Study of Atherosclerosis. Int J Nephrol. 2011;2011:153868. PMCID: 3184416.
76. Anderson JS, Nettleton JA, Hundley WG, Tsai MY, Steffen LM, Lemaitre RN, Siscovick D, Lima
J, Prince MR, Herrington D. Associations of plasma phospholipid omega-6 and omega-3
polyunsaturated Fatty Acid levels and MRI measures of cardiovascular structure and function: the
multiethnic study of atherosclerosis. J Nutr Metab. 2011;2011:315134. PMCID: 3159987.
77. Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, Sonestedt E, Ngwa JS,
Wojczynski MK, Lemaitre RN, Gustafsson S, Anderson JS, Tanaka T, Hindy G, Saylor G, Renstrom
F, Bennett AJ, van Duijn CM, Florez JC, Fox CS, Hofman A, Hoogeveen RC, Houston DK, Hu FB,
Jacques PF, Johansson I, Lind L, Liu Y, McKeown N, Ordovas J, Pankow JS, Sijbrands EJ, Syvanen
AC, Uitterlinden AG, Yannakoulia M, Zillikens MC, Wareham NJ, Prokopenko I, Bandinelli S,
Forouhi NG, Cupples LA, Loos RJ, Hallmans G, Dupuis J, Langenberg C, Ferrucci L, Kritchevsky SB,
McCarthy MI, Ingelsson E, Borecki IB, Witteman JC, Orho-Melander M, Siscovick DS, Meigs JB,
Franks PW, Dedoussis GV. Total zinc intake may modify the glucose-raising effect of a zinc
transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407-16. PMCID:
3161318.
78. Sellers MB, Newby LK. Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly
patients. Am Heart J. 2011;161(2):241-6.
79. Shah S. Wake Forest Baptist First Hospital in North Carolina to Implant Newly Approved Device
to Treat Heart Failure. American City Business Journals; 2011.
80. Stacey RB, Kock ND, D'Agostino JRB, Torti FM, Eckman DM, Sane DC, Workman S, Lane KS,
Hundley WG. Doxorubicin Associated Changes In Coronary Artery Histology. Journal Of The
American College Of Cardiology. 2011;57(14s1):E1591-E.
81. Yeboah J. Flaws in Current Clinical Trial Design: Need for Intermediate Markers. J Postgenom
Drug Biomark Develop. 2011;1():102e.
82. Yeboah J, Bertoni AG, Herrington DM, Post WS, Burke GL. Impaired Fasting Glucose and the
Risk of Incident Diabetes Mellitus and Cardiovascular Events in an Adult Population MESA
(Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58(2):140-6.
83. Yeboah J, Nyinaku P. Vitamin D supplementation and cardiovascular outcomes in blacks. Am J
Hypertens. 2011;24(5):505.
84. Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, Burke GL, Herrington DM.
Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an
adult population: MESA. Atherosclerosis. 2011;219(2):963-8. PMCID: 3255297.
85. Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, Sonestedt E, Ngwa JS,
Wojczynski MK, Lemaitre RN, Gustafsson S, Anderson JS, Tanaka T, Hindy G, Saylor G, Renstrom
F, Bennett AJ, van Duijn CM, Florez JC, Fox CS, Hofman A, Hoogeveen RC, Houston DK, Hu FB,
Jacques PF, Johansson I, Lind L, Liu Y, McKeown N, Ordovas J, Pankow JS, Sijbrands EJ, Syvanen
AC, Uitterlinden AG, Yannakoulia M, Zillikens MC, Investigators M, Wareham NJ, Prokopenko I,
Bandinelli S, Forouhi NG, Cupples LA, Loos RJ, Hallmans G, Dupuis J, Langenberg C, Ferrucci L,
Kritchevsky SB, McCarthy MI, Ingelsson E, Borecki IB, Witteman JC, Orho-Melander M, Siscovick
DS, Meigs JB, Franks PW, Dedoussis GV. Total zinc intake may modify the glucose-raising effect of a
zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407-16.
86. Shah SA, Herrington DM, Howard TD, Divers J, Arnett DK, Burke GL, Kao WH, Guo X,
Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich SS, Bowden DW, W. P.
Associations Between Genetic Variations in NOS1AP and QT Interval Duration in Four Racial/Ethnic
Groups in the Multi-Ethnic Study of Atherosclerosis (MESA). Annals of Noninvasive
Electrocardiology In Press, 2012.
87. Agarwal S, Jacobs DR, Jr., Vaidya D, Sibley CT, Jorgensen NW, Rotter JI, Chen YD, Liu Y,
Andrews JS, Kritchevsky S, Goodpaster B, Kanaya A, Newman AB, Simonsick EM, Herrington DM.
Metabolic Syndrome Derived from Principal Component Analysis and Incident Cardiovascular Events:
The Multi Ethnic Study of Atherosclerosis (MESA) and Health, Aging, and Body Composition (Health
ABC). Cardiol Res Pract. 2012:919425. PMCID: 3318892.
88. Cox A, Agarwal S, Herrington D, Carr J, Freedman B, Bowden D. C-reactive protein
concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study. Diabet Med.
2012;29(6):767-70. PMCID: PMC Journal - In Process.
89. Kawel N, Nacif M, Arai AE, Gomes AS, Hundley WG, Johnson WC, Prince MR, Stacey RB,
Lima JA, Bluemke DA. Trabeculated (noncompacted) and compact myocardium in adults: the
multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2012;5(3):357-66. PMCID: 3399115.
90. Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat
Rev Clin Oncol. 2012;9(5):288-96.
91. Mann DM, Shimbo D, Cushman M, Lakoski S, Greenland P, Blumenthal RS, Michos ED,
Lloyd-Jones DM, Muntner P. C-Reactive Protein Level and the Incidence of Eligibility for Statin
Therapy: The Multi-Ethnic Study of Atherosclerosis. Clin Cardiol. 2012.
92. Martinez-Rumayor AA, de Lemos JA, Rohatgi AK, Ayers CR, Powell-Wiley TM, Lakoski SG,
Berry JD, Khera A, Das SR. Addition of Highly Sensitive Troponin T and N-Terminal Pro-B-Type
Natriuretic Peptide to Electrocardiography for Detection of Left Ventricular Hypertrophy: Results
From the Dallas Heart Study. Hypertension. 2012.
93. Mathieu RAt, Powell-Wiley TM, Ayers CR, McGuire DK, Khera A, Das SR, Lakoski SG.
Physical activity participation, health perceptions, and cardiovascular disease mortality in a multiethnic
population: the Dallas Heart Study. Am Heart J. 2012;163(6):1037-40. PMCID: 3514075.
94. Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, Peralta CA. Subclinical cardiac
abnormalities and kidney function decline: the multi-ethnic study of atherosclerosis. Clin J Am Soc
Nephrol. 2012;7(7):1137-44. PMCID: 3386670.
95. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS,
Ward RP, Douglas PS, Altus P, Barnard DD, Blankenship JC, Casey DE, Jr., Dean LS, Fazel R,
Gilchrist IC, Kavinsky CJ, Lakoski SG, Le DE, Lesser JR, Levine GN, Mehran R, Russo AM,
Sorrentino MJ, Williams MR, Wong JB, Wolk MJ, Hendel RC, Kramer CM, Min JK, Shaw L,
Stainback RF, Allen JM.
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use
criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use
Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association
for Thoracic Surgery American Heart Association, American Society of Echocardiography American
Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of
Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular
Magnetic Resonance Society of Thoracic Surgeons. Catheter Cardiovasc Interv. 2012;80(3):E50-81.
96. Ren J, Lakoski S, Haller RG, Sherry AD, Malloy CR. Dynamic monitoring of carnitine and
acetylcarnitine in the trimethylamine signal after exercise in human skeletal muscle by 7T (1) H-MRS.
Magn Reson Med. 2012.
97. Riley R, Don C, Aldea G, Mokadam N, Probstfield J, Maynard C, Goss J. Recent Trends in
Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in
Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
Journal of the American Heart Association. 2012;1(5). PMCID: PMC Journal - In Process.
98. Yeboah J. Predicting Heart Attack Risk: A Calcium Test May Help. Time, Inc.; 2012 [updated
2012; cited August 22, 2012]; Available from.
99. Yeboah J. Which Heart Risk Test Rates Best? : WebMD, LLC; 2012 [updated 2012; cited
August 21, 2012]; Available from.
100. Yeboah J. 2 Tests May Improve Heart Patients' Care, Studies Suggest. US News and World
Report, LP; 2012 [updated 2012; cited August 21, 2012]; Available from.
101. Yeboah J. Cardiovascular Risk Prediction: Two More Studies, Little Progress. Forbes.com, LLC;
2012 [updated 2012; cited August 21, 2012]; Available from.
102. Yeboah J. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound
or flawed? Atherosclerosis. 2013;226(2):335-6.
103. Yeboah J, McClelland RL, Polonsky TS, Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC,
Greenland P, Herrington DM. Comparison of novel risk markers for improvement in cardiovascular
risk assessment in intermediate-risk individuals. JAMA. 2012;308(8):788-95. PMCID: PMC Journal In Process.
104. Yeboah J, Rodriguez CJ, Stacey B, Lima JA, Liu S, Carr JJ, Hundley WG, Herrington DM.
Prognosis of Individuals with Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic
Study of Atherosclerosis (MESA). Circulation. 2012;126(23):2713-9. PMCID: 3533250.
105. Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, Carr JJ, Bowden DW.
Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes
Care. 2013;36(4):972-7. PMCID: 3609509.
106. Ahmed HM, Blaha MJ, Nasir K, Jones SR, Rivera JJ, Agatston A, Blankstein R, Wong ND,
Lakoski S, Budoff MJ, Burke GL, Sibley CT, Ouyang P, Blumenthal RS. Low-risk lifestyle, coronary
calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol.
2013;178(1):12-21. PMCID: 3698994.
107. Al-Mallah MH, Qureshi W, Lin FY, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Chang
HJ, Cademartiri F, Chinnaiyan K, Chow BJ, Cheng VY, Delago A, Gomez M, Hadamitzky M,
Hausleiter J, Kaufmann PA, Leipsic J, Maffei E, Raff G, Shaw LJ, Villines TC, Cury RC, Feuchtner G,
Plank F, Kim YJ, Dunning AM, Min JK. Does coronary CT angiography improve risk stratification
over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results
from the prospective multicenter international CONFIRM registry. Eur Heart J Cardiovasc Imaging.
2013.
108. Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal S, Malouf J, Araoz P, Michelena H, Cueff
C, Larose E, Capoulade R, Vahanian A, Enriquez-Sarano M. The complex nature of Discordant Severe
Calcified Aortic Valve Disease Grading: New Insights from combined Doppler-Echocardiographic and
Computed Tomographic Study. J Am Coll Cardiol. 2013.
109. Dawood FZ, Khan F, Roediger MP, Zhang ZM, Swaminathan S, Klinker H, Hoy J, Lundgren JD,
Neaton JD, Soliman EZ. Electrocardiographic spatial QRS-T angle and incident cardiovascular disease
in HIV-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART]
study). Am J Cardiol. 2013;111(1):118-24. PMCID: 3525800.
110. Eckman DM, Stacey RB, Rowe R, D'Agostino R, Jr., Kock ND, Sane DC, Torti FM, Yeboah J,
Workman S, Lane KS, Hundley WG. Weekly doxorubicin increases coronary arteriolar wall and
adventitial thickness. PLoS One. 2013;8(2):e57554. PMCID: 3578811.
111. Hassan SA, Amer S, Qureshi W, Alirhayim Z, Kuriakose P. Treating symptomatic coronary
artery disease in patients with Von Willebrand disease. Hematol Oncol Stem Cell Ther. 2013;
6(3-4):101-4.
112. Khalid F, Qureshi W, Qureshi S, Alirhayim Z, Garikapati K, Patsias I. Impact of restarting
warfarin therapy in renal disease anticoagulated patients with gastrointestinal hemorrhage. Ren Fail.
2013;35(9):1228-35.
113. Lakoski SG. Fitness protects you from cancer, even 20 years later 2013 [updated 2013; cited];
Available from.
114. Lakoski SG, Barlow CE, Koelwyn GJ, Hornsby WE, Hernandez J, Defina LF, Radford NB,
Thomas SM, Herndon JE, 2nd, Peppercorn J, Douglas PS, Jones LW. The influence of adjuvant
therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper
Center Longitudinal Study. Breast Cancer Res Treat. 2013;138(3):909-16. PMCID: 3640334.
115. Lakoski SG, Mallick H, McClure LA, Safford M, Kissela B, Howard G, Cushman M. A risk
algorithm for assessing short-term mortality for obese black and white men and women. Obesity
(Silver Spring). 2013.
116. Li Y, Dawood FZ, Chen H, Jain A, Walsh JA, 3rd, Alonso A, Lloyd-Jones DM, Soliman EZ.
Minor isolated Q waves and cardiovascular events in the MESA study. Am J Med. 2013;126(5):450
e9- e16. PMCID: 3741651.
117. Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR,
Banks-Richard K, Albert MA. Relationship between perceptions about neighborhood environment and
prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013;21(1):E14-21.
PMCID: 3602329.
118. Qureshi W, Hassan S, Khalid F, Almahmoud MF, Shah B, Tashman R, Ambulgekar N, El-Refai
M, Mittal C, Alirhayim Z. Outcomes of correcting hyponatremia in patients with myocardial infarction.
Clin Res Cardiol. 2013;102(9):637-44.
119. Qureshi W, Mittal C, Ahmad U, Alirhayim Z, Hassan S, Qureshi S, Khalid F. Clinical predictors
of post-liver transplant new-onset heart failure. Liver Transpl. 2013;19(7):701-10.
120. Riley RF, Newby LK, Don CW, Alexander KP, Peterson ED, Peng SA, Gandhi SK, Kutcher MA,
Amsterdam EA, Herrington DM. Guidelines-based treatment of anaemic STEMI patients: practice
patterns and effects on in-hospital mortality: a retrospective analysis from the NCDR. European Heart
Journal: Acute Cardiovascular Care. 2013;2(1):35-43.
121. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington
DM. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment
elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from
the American Heart Association Mission: Lifeline program. Am Heart J. 2013;165(1):50-6. PMCID:
3523309.
122. Samsky M, Patel CB, Owen A, Schulte PJ, Jentzer J, Rosenberg PB, Felker GM, Milano CA,
Hernandez AF, Rogers JG. Ten Year Experience with Extended Criteria Cardiac Transplantation. Circ
Heart Fail. 2013;6(6):1230-8.
123. Savage PD, Lakoski SG, Ades PA. Course of body weight from hospitalization to exit from
cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2013;33(5):274-80.
124. Scott JM, Lakoski S, Mackey JR, Douglas PS, Haykowsky MJ, Jones LW. The potential role of
aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics. Oncologist.
2013;18(2):221-31. PMCID: 3579607.
125. Shah SA, Herrington DM, Howard TD, Divers J, Arnett DK, Burke GL, Kao WH, Guo X,
Siscovick DS, Chakravarti A, Lima JA, Psaty BM, Tomaselli GF, Rich SS, Bowden DW, Post W.
Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in
four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Noninvasive
Electrocardiol. 2013;18(1):29-40. PMCID: PMC3642094.
126. Shah SA, Kambur T, Chan C, Herrington DM, Liu K, Shah SJ. Relation of Short-Term Heart
Rate Variability to Incident Heart Failure (from the Multi-Ethnic Study of Atherosclerosis). Am J
Cardiol. 2013. PMCID: PMC3735865.
127. Stacey RB, Hundley WG. The Role of Cardiovascular Magnetic Resonance (CMR) and
Computed Tomography (CCT) in Facilitating Heart Failure Management. Curr Treat Options
Cardiovasc Med. 2013;15(4):373-86. PMCID: 3767383.
128. Upadhya B, Ntim W, Brandon Stacey R, Henderson R, Leedy D, O'Brien FX, Knovich MA.
Prolongation of QTc intervals and risk of death among patients with sickle cell disease. Eur J
Haematol. 2013;91(2):170-8.
129. Yeboah J. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound
or flawed? Atherosclerosis. 2013;226(2):335-6.
130. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ.
Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and
all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol.
2013.
131. Yeboah J, Herrington DM. Intermediate end point cardiovascular clinical trials: an excellent idea
based on an obsolete paradigm. Expert Rev Cardiovasc Ther. 2013.
132. Ahmed FS, Jiang XC, Schwartz JE, Hoffman EA, Yeboah J, Shea S, Burkart KM, Barr RG.
Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study.
Biomarkers. 2014;19(3):207-13. PMCID: 4088962.
133. Balfour PC, Jr., Rodriguez CJ, Ferdinand KC. Blood pressure and cardiovascular effects of new
and emerging antidiabetic agents. Curr Hypertens Rep. 2014;16(8):455.
134. Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, Carr JJ, Freedman BI,
Herrington DM, Bowden DW. Heart rate-corrected QT interval is an independent predictor of all-cause
and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes
Care. 2014;37(5):1454-61.
135. Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF,
Lundgren JD, Neaton JD, Soliman EZ. Determinants of developing widened spatial QRS-T angle in
HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy
[SMART] Study. J Electrocardiol. 2014;47(2):264-71. PMCID: 3951578.
136. Hassan M, Qureshi W, Sroujieh LS, Albashaireh D, BouMalham S, Liroff M, Amjad W, Khalid
F, Hadid H, Alirhayim Z. Interplay of parathyroid hormone and aldosterone antagonist in prevention of
heart failure hospitalizations in chronic kidney disease. J Renin Angiotensin Aldosterone Syst. 2014.
137. Jordan JH, Haag JC, Morgan TM, Vasu S, Stacey B, Hamilton C, Robinson K, Kitzman D,
Thohan V, Hundley WG. Small, short-duration, dobutamine-induced perfusion defects are not
associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic
resonance stress imaging. J Comput Assist Tomogr. 2014;38(3):427-33. PMCID: 4103171.
138. Lakoski SG, Kozlitina J. Ethnic differences in physical activity and metabolic risk: the Dallas
Heart Study. Med Sci Sports Exerc. 2014;46(6):1124-32.
139. Manichaikul A, Rich SS, Perry H, Yeboah J, Law M, Davis M, Parker M, Ragosta M, Connelly
JJ, McNamara CA, Taylor AM. A Functionally Significant Polymorphism in ID3 Is Associated with
Human Coronary Pathology. PLoS One. 2014;9(3):e90222.
140. Mittal C, Qureshi W, Singla S, Ahmad U, Huang MA. Pre-transplant left ventricular diastolic
dysfunction is associated with post transplant acute graft rejection and graft failure. Dig Dis Sci.
2014;59(3):674-80.
141. Peel AB, Thomas SM, Dittus K, Jones LW, Lakoski SG. Cardiorespiratory fitness in breast
cancer patients: a call for normative values. J Am Heart Assoc. 2014;3(1):e000432. PMCID: 3959685.
142. Qureshi W, Mittal C, Patsias I, Garikapati K, Kuchipudi A, Cheema G, Elbatta M, Alirhayim Z,
Khalid F. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial
fibrillation. Am J Cardiol. 2014;113(4):662-8.
143. Qureshi W, Shah AJ, Salahuddin T, Soliman EZ. Long-term mortality risk in individuals with
atrial or ventricular premature complexes (results from the Third National Health and Nutrition
Examination Survey). Am J Cardiol. 2014;114(1):59-64.
144. Scott JM, Jones LW, Hornsby WE, Koelwyn GJ, Khouri MG, Joy AA, Douglas PS, Lakoski SG.
Cancer therapy-induced autonomic dysfunction in early breast cancer: implications for aerobic exercise
training. Int J Cardiol. 2014;171(2):e50-1. PMCID: 4116686.
145. Soliman EZ, Cammarata M, Li Y. Explaining the inconsistent associations of PR interval with
mortality: The role of P-duration contribution to the length of PR interval. Heart Rhythm.
2014;11(1):93-8.
146. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA, Thacker EL, Judd S,
Howard VJ, Howard G, Herrington DM, Cushman M. Atrial fibrillation and the risk of myocardial
infarction. JAMA Intern Med. 2014;174(1):107-14.
147. Stacey RB, Andersen M, Haag J, Hall ME, McLeod G, Upadhya B, Hundley WG, Thohan V.
Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy.
Am J Cardiol. 2014;113(6):1018-23. PMCID: 3969853.
148. Upadhya B, Stacey RB, Ntim W, Knovich MA, Pu M. Echocardiography-derived tricuspid
regurgitant jet velocity is an important marker for the progression of sickle-cell disease. Acta
Haematol. 2014;132(2):152-8.
149. Yeboah J, Delaney JA, Nance R, McClelland RL, Polak JF, Sibley CT, Bertoni A, Burke GL,
Carr JJ, Herrington DM. Mediation of cardiovascular risk factor effects through subclinical vascular
disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(8):1778-83.
150. Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jöckel
K-H, Burke GL, Wong ND, Lehmann N, Herrington DM, Möhlenkamp S, Greenland P. Development
of a New Diabetes Risk Prediction Tool for Incident Coronary Heart Disease Events: The Multi-Ethnic
Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2014;Published online
August 13, 2014; http://dx.doi.org/10.1016/j.atherosclerosis.2014.07.035.
151. Howard T, Mathias R, Seeds M, Herrington D, Hixson J, Shimmin L, Hawkins G, Sellers M,
Ainsworth H, Sergeant S, Miller L, Chilton S. DNA Methylation in an Enhancer Region of the FADS
Cluster is associated with FADS Activity in Human Liver. PLoS. 2014 In Press.
152. Stacey B, Haag J, Hall M, G. M, Upadhya B, Hundley G, Thohan V. Mitral Regurgitation in Left
Ventricular Noncompaction Cardiomyopathy from Cardiac MRI. J Heart Valve Dis. 2014, In Press.
153. Gibson O, Blaha MJ, Arnan M, Sacco R, Szklo M, Herrington D, Yeboah J. Coronary Artery
calcium and incident cerebrovascular events in an asymptomatic multi-ethnic cohort. J Am Coll
Cardiol. 2014, In Press.
154. Yeboah J. Coronary Artery Calcium Scores Identify People at Risk for Heart Attacks. The MESA
Messenger-Newsletter of the Multi-Ethnic Study of Atherosclerosis. Spring 2013 No. 5.
Book Chapters:
1. Shah SA. Case: 23 year-old with recurrent seizures (Bechet’s Disease). Medicine/Pediatrics
Case-Based Review. AJ Liles and RM Wardrop. McGraw-Hill Specialty Board Review. 2008: Vol1.
2.
Humphrey H, Shah SA, and Shah S. Case: 59 year-old with ”ST- Elevation MI” (Takotsubo
cardiomyopathy). Medicine/Pediatrics Case-Based Review. AJ Liles and RM Wardrop. McGraw-Hill
Specialty Board Review. 2008: Vol1.
3. Waqas Qureshi, Alec J. Moorman, Micah J. Eimer, Mihai Gheorghiade. Chapter 7: Early
Medical Management of Hospitalization for Heart Failure. In Baliga R, Givertz M, Pitt B. eds Medical
Management of Heart Failure; Volume 1: Medical 2nd Edition New York: Springer Science and
Buisiness Media, 2013 (in press)
Abstracts:
1. Daniel K, Brosnihan K, Fray B, Stewart K, Kitzman D. Renin-Angiotensin-Aldosterone System
Activation in Diastolic Heart Failure: Comparison with Systolic Heart Failure and Age-Matched
Normal Subjects. Scientific Session of the American College of Cardiology 2005.
2. Lakoski S, Cushman M, Blumenthal R, Criqui M, Detrano R, Rundek T, D'Agostino R, Herrington
D. Gender and C-Reactive Protein: Data from the Multi-Ethnic Study of Atherosclerosis (MESA)
Cohort. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April
Circulation Vol 11;14, P152; 2005.
3. Lakoski S, Herrington D, Siscovick D, Hulley S. C-reactive protein and incident hypertension in
young adults: the CARDIA Study. AHA Scientific Sessions; Nov 2005.
4. Lakoski S, Li L, Langefeld C, Liu Y, Howard T, Zu J, Bowden D, Herrington D. Variation in innate
immunity gene (IRAK1) is associated with c-reactive protein in Caucasian women in the Diabetes
Heart Study (DHS). AHA Scientific Sessions; Nov Circulation 2005; 112 (Suppl II):II-785; 2005.
5. Lakoski SG. The Association between Inflammation and Hypertension. Cardiovascular
Epidemiology, Biostatistics and Behavioral Medicine Trainee Session: 45th Annual Conference on
Cardiovascular Disease Epidemiology and Prevention; April 2005.
6. Mellen P, Herrington D. Diabetes, but not the Metabolic Syndrome, Predicts Coronary
Atherosclerotic Progression in Postmenopausal Women: the ERA Study. AHA 45th Annual
Conference on Cardiovascular Disease Epidemiology and Prevention; April Washington, D.C.:
Circulation;111(14):e205; 2005.
7. Mellen P, Herrington D. Insulin Resistance and Atherosclerotic Progression: the ERA Study. AHA
45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; April 2005;
Washington, D.C.: Circulation ;111(14):e205; 2005.
8. Mellen P, Herrington D. Post-Challenge Glucose – How Low Should You Go?: High-Normal
Two-Hour Glucose Predicts Coronary Disease Progression in Postmenopausal Women. . AHA
Scientific Sessions; Nov Dallas, TX: Circulation;112(17):II-820; 2005.
9. Daniel K, Johnston, Bertoni A, Ding J, Budoff M, Bluemke D, Carr J. Using Non-Contrast
Enhanced Computed Tomography to Measure Ventricular Size: Comparison of Methods. 46th
Annual Conference on Cardiovascular Disease Epidemiology and Prevention conference March 2006.
10. Daniel K, Kutcher M, Applegate R, Herrington D. Clinical and Angiographic Risk Factors for
Mechanical Obstruction and No Reflow Following Percutaneous Coronary Intervention. AHA
Scientific Sessions; Oct 31: Circulation,114(18); 2006.
11. Daniel K, Parks J, Schreiner P, Tsai M, Post W, Palmas W, Herrington D. Polymorphisms in
ABCA1 are Associated with Serum Levels of IL-6 and CRP. 46th Annual Conference on
Cardiovascular Disease Epidemiology and Prevention March 2006.
12. Lakoski S, Brosnihan K, Herrington D. Interleukin-10Concentration and Coronary Heart Disease
(CHD) Event Risk in the Estrogen Replacement and Atherosclerosis (ERA) Study: American Heart
Association Scientific Sessions. AHA Scientific Sessions; Oct 31,2006.: Circulation. Vol 114(18); ;
2006.
13. Mellen P, Herrington D. Nutrient Intake and Urinary Albumin Excretion in Nondiabetics: the
National Health and Nutrition Examination Survey, 2001-2002. . AHA 46th Annual Conference on
Cardiovascular Disease Epidemiology and Prevention: Circulation;113:e373. ; 2006.
14. Yeboah J, Crouse J, Burke G, Hsu F, Herrington D. Flow-Mediated Dilation of Brachial Artery
Predicts Incident Cardiovascular Events In Older Adults (Cardiovascular Health Study). . AHA
Scientific Session Nov Circulation; Vol 114,(18); 2006.
15. Yeboah J, Crouse J, Sane D, Herrington D, Lohman K. Plasma Platelet Derived Growth Factor-BB
Levels in Diabetics with Cardiovascular Events (DHS). 66th Annual American Diabetic Association
Scientific Session June 2006.
16. Yeboah J, Sane D, Herrington D, Crouse J. P176 Plasma Platelet Derived Growth Factor-bb
Levels in Diabetics with Negligible Coronary Artery Calcium Scores (Diabetes Heart Study). 7th
Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, ; April 2006.
17. Jain M, Shah M, Matulevicius S, Peshock R. Correlation between diastolic dysfunction and aortic
compliance in Dallas Heart Study population using peak filling rate as a measure of diastolic
dysfunction by cardiac magnetic resonance imaging. American Heart Association 2007.
18. John JM. The Determinants of Exercise Tolerance in Diastolic Heart Failure Patients. Ohio
Chapter of the American College of Cardiology 2007.
19. Lakoski S, Cushman M, Siscovick D, Blumenthal R, Burke G, Palmas W, Herrington D. The
relationship between inflammation, obesity, and risk for hypertension in the multi-ethnic study of
atherosclerosis (MESA). Finalist: poster competition. AHA Scientific Sessions 2007.
20. Lehtinen A, Newton-Cheh C, Ziegler J, Langefeld C, Freedman B, Daniel K, Herrington D,
Bowden D. Association of NOS1AP genetic variants with QT interval duration in families from the
Diabetes Heart Study. AHA Scientific Sessions Nov 2007.
21. Nelson M, Daniel K, Carr J, Freedman B, Prineas R, Bowden D, Herrington D. Associations
between electrocardiographic interval durations and coronary calcium scores: The Diabetes Heart
Study. AHA-Epidemiology Council Meeting; March 2007.
22. Putney D, Matura L, Daniel K, Thohan V. Negative impact of nesiritide in combination with
inotropic therapy among patients admitted with acute heart failure.: JACC; 49(9 supplement
1);1022-66-76A; 2007.
23. Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Westcott C, Assimos D, Stratta R,
Adams P, Hartmann E. Impact of ethnicity on living kidney donation.: Am. J. Transplantation
2007;7(supplement 2):218; 2007.
24. Sturek J, Hedrick C, Mauldin J, Huang C, Carr J, Swords-Jenny N, Goodarzi M, Taylor K, Rotter J,
Adar S, Kao W, Post W, Daniel K, Rich S. ABCG1 SNPs and variation in lipid levels in the
Multi-Ethnic Study of Atherosclerosis (MESA). Clinical Cardiovascular Genomics Meeting Oct
2007.
25. Yeboah J, Burke G, Mcburnie M, Sutton-Tyrrell K, Crouse J, Herrington D. Association of
Endothelial Function and Cardiovascular Disease Status in an Elderly Cohort: The Cardiovascular
Health Study. AHA Annual Conference on Cardiovasular Disease Epidemiology and Prevention in
Association w/the Council on Nutrition, Physical Activity and Metabolism; Feb 2007.
26. Daniel K, Hedrick C, Rich S, Allison M, Post W, Tsai M, Palmas W, McClelland R, O’Leary D,
Herrington D. Cholesterol ester transfer protein (CETP) polymorphisms are associated with
lipoproteins and subclinical atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).
American Heart Association - Epidemiology Council Conference March 2008.
27. Duprez D, Jacobs D, Lutsey P, Herrington D, Prime D, Ouyang P, Barr G, Bluemke D.
Relationship Between Endothelial, Inflammatory, Thrombotic Markers and Large and Small Artery
Elasticity – Results of the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort Study. ACC 57th
Annual Scientific Session March JACC:51;A300-3001; 2008.
28. Duprez D, Jacobs D, Lutsey P, Herrington D, Prime D, Ouyang P, Barr G, Bluemke D.
Relationship Between Endothelial, Inflammatory, Thrombotic Markers and Large and Small Artery
Elasticity – Results of the Multi-Ethnic Study of Atherosclerosis (MESA) Cohort Study. NHLBI
Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee Session in conjunction
with the 48th Cardiovascular Disease Epidemiology and Prevention Conference, and Nutrition,
Physical Activity and Metabolism Conference 2008.
29. Hall W, Scheunemann L, Truitt S, Shah S, Polisner D, Rivera M, Parker L, Carson S. The
Prevalence of Clinically Relevant Incidental Findings on Chest CT Angiograms Ordered to Diagnose
Pulmonary Embolism. American Thoracic Society (ATS) National Conference 2008.
30. Hussein A, Imran N, John J, Durham S, Kanjwal Y. Post Coronary Artery Bypass Graft Surgery
Left Ventricular Dysfunction and Prophylactic Implantable Cardiac Defibrillators: Do Patients Fall
ThroughThe Cracks? . Heart Rhythm Society's 29th Annual Scientific Sessions 2008.
31. Jain M, Matulevicius S, Leonard D, Shah M, Peshock R. Prediction of Left Ventricular Peak
Filling Rate by Three Short Axis Cardiac Magnetic Resonance Imaging Slices. . Society of
Cardiovascular Magnetic Resonance 2008.
32. McKimmie R, Daniel K, Carr J, Bowden D, Freedman B, Register T, Hsu F-C, Lohman K,
Weinberg R, Wagenknecht L. Hepatic Steatosis and subclinical cardiovascular disease in a cohort
enriched for type 2 diabetes: the Diabetes Heart Study. American Heart Association - Epidemiology
Council Conference March 2008.
33. Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: A
meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 2008;18(4):283-90.
34. Prime D, Brumback L, Arnett D, Heckbert S, Duprez D, Jacobs D, Herrington D, Bluemke D,
Lima J. Relationship between increased pulse pressure measured by radial arterial tonometry or by
brachial cuff, and increased left ventricular mass (LVM): The Multi Ethnic Study of Atherosclerosis
(MESA). NHLBI Cardiovascular Epidemiology, Biostatistics and Behavioral Medicine Trainee
Session in conjunction with the 48th Cardiovascular Disease Epidemiology and Prevention
Conference, and Nutrition, Physical Activity and Metabolism Conference March 2008.
35. Reeves-Daniel A, Daniel K, Assimos D, Westcott C, Rogers J, Farney A, Stratta R, Hartmann E,
Adams P, Bleyer A, Freedman B. Similar short-term outcomes among African Americans and
Caucasians following live kidney donation.: Am. J. Transplantation 2008;8(supplement 2):191; 2008.
36. Shah S, Herrington D, Howard T, Burke G, Bowden D, Hong W, Kao L, Chakravarti A, Lima J,
Tomaselli G, Post W, Guo X, Siscovick D, Psaty B, Rich S. Associations Between Genetic Variations
in NOS1AP and QT Interval Duration in Four Racial/Ethnic Groups in the Multi-Ethnic Study of
Atherosclerosis (MESA). AHA Scientific Sessions November 2008.
37. Shah S, Lehtinen A, Nelson M, Freedman B, Bowden D, Daniel K, Herrington D. Relationship
Between Genetic Variants in Myocardial Sodium and Potassium Channel Genes and QT Duration in
Diabetics: The Diabetes Heart Study. Poster presentation. 48th Cardiovascular Disease
Epidemiology and Prevention Conference, and Nutrition, Physical Activity and Metabolism
Conference; March 2008.
38. Stacey R, Bertoni A, Eng J, Bluemke D, Hundley WG, Herrington D. Modification of the Effect of
Glycemic Status on Aortic Distensibility by Age in the Multi-Ethnic Study of Atherosclerosis. AHA
Scientific Session 2008.
39. Stacey R, Daniel K, Bertoni A, Carr J, Freedman B, Bowden D, Herrington D. Relationships
between Cardiovascular Risk Factors and Biventricular Volume in the Diabetes Heart Study.
American Heart Association - Epidemiology Council Conference March 2008.
40. Truitt S, Hall W, Rivera M, Scheunemann L, Shah S, Polisner D, Parker L, Carson S. Incidental
Pulmonary Nodules Found on CT Angiograms: Characteristics and Recommended Follow Up. ATS
National Conference 2008.
41. Yeboah J, Johnson C, Burke G, Polak J, Post W, Lima J, Folsom A, Crouse J, Herrington D.
Predictive Value of Brachial Flow-Mediated Dilation for Incident Cardiovascular Events in Population
Based Adults: The Multi-Ethnic Study of Atherosclerosis. Accepted for presentation as a finalist for
2008 Elizabeth Barrett-Connor Research Award for Young Investigators in Training. Finalist for
2008 Elizabeth Barrett-Connor Research Award for Young Investigators in Training
AHA-Epidemiology Council Conference 2008.
42. Yeboah Y, Polak J, Burke G, Crouse J, Bluemke D, Lima J, Herrington D. Endothelial
Dysfunction is Associated With Left Ventricular Mass and Left Ventricular Ejection Fraction (assessed
using MRI) Independent of Blood Pressure and Antihypertensive Medication Use (MESA). AHA
Scientific Session 2008
43. Lambert N, Sacrinty M, Ketch T, Turner S, Santos R, Daniel K, Applegate R, Kutcher M, Sane D.
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with
myocardial infarction. American College of Cardiology Annual Scientific Session 2009.
44. Mellen PB, Goff DC. Low Prevalence of Lipid Targets Met Among US Adults With
Cardiometabolic Risk: NHANES 2005-6. Circulation. 2009;120(18):S496-S.
45. Agarwal S, Houston DK, Tooze JA, Bauer DC, Cauley JA, Harris TB, Koster A, Womack C,
Kritchevsky SB. Association between 25-hydroxyvitamin D levels and metabolic syndrome in older
adults. . AHA Scientific Session 2010.
46. Agarwal S, Morgan T, Herrington D, Su J, Freedman B, Carr J, Bowden D. Risk stratification in a
diabetic population with metabolic syndrome using coronary calcium scores: Diabetes Heart Study.
AHA Scientific Session 2010.
47. Agarwal S, Morgan T, Herrington D, Xu J, Freedman B, Carr J, Bowden D. Risk stratification in a
diabetic population with metabolic syndrome using coronary calcium scores: Diabetes Heart Study.
AHA Scientific Session 2010.
48. Agarwal S, Rotter J, Vaidya D, Jorgensen N, Jacobs D, Sibley C, Chen YD, Herrington D.
Metabolic Syndrome and Principal Component Analysis: Multi-Ethnic Study of Atherosclerosis
(MESA). AHA Scientific Session 2010.
49. Agarwal S, Tohan V, Shlipak M, Lima J, Bluemke DA, Sisocivck D, Gomes A, Herrington D.
Association between cystatin and left ventricular structure and function in the Multi-Ethnic Study of
Atherosclerosis. AHA Scientific Session 2010.
50. Ahmed FS, Jiang X-C, Hoffman EA, Yeboah J, Burkart KM, Shea S, Barr RG. Plasma
Sphingomyelin And Progression Of Subclinical Pulmonary Emphysema In A Population Based
Cohort. The MESA Lung Study. Am J Respir Crit Care Med. 2010;181(1_MeetingAbstracts):A3134-.
51. Allen S, Cushman M, Sane D, Johnson C, Herrington D. The Association of COX-2 Inhibitors and
Non-selective Nonsteroidal Anti-Inflammatory Medications with D-dimer in the Multi-Ethnic Study of
Atherosclerosis (MESA). ACC Scientific Session; March 2010.
52. Anderson J, Nettleton J, Herrington D, Johnson C, Tsai M, Siscovick D. Relationship of Dietary
Fish Intake with Brachial Artery Flow-Mediated Dilation in the Multi-Ethnic Study of Atherosclerosis
(MESA). . 50th Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical
Activity and Metabolism Conference, NHLBI Trainee Session on Epidemiology; March 2010.
53. Anderson JS, Nettleton JA, Hundley G, Tsai MY, Steffen L, Lemaitre RN, Siscovick D, Lima J,
Prince MA, Herrington DM. Abstract 10882: The Associations of Plasma Phospholipid Omega-6 and
Omega-3 Fatty Acid Levels and Cardiac Magnetic Resonance Imaging Measures of Left Ventricular
Structure and Function: The Multi-Ethnic Study of Atherosclerosis. Circulation.
2010;122(21_MeetingAbstracts):A10882-.
54. Jain M, Ding J, Allison M, Criqui M, Carr J, Herrington D. Association of Visceral Adipose
Tissue with Pulse Pressure in the Multi Ethnic Study of Atherosclerosis Pressure (MESA). 50th
Cardiovascular Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and
Metabolism Conference 2010.
55. Jain M, Herrington D, Hundley WG, Bluemke D, Bertoni A. Association of Physical Activity with
Pulse Pressure in the Multi-Ethnic Study of Atherosclerosis (MESA). 50th Cardiovascular Disease
Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference 2010.
56. Shah S, Chan C, Tandri H, Brown E, Herrington D, Liu K, Shah SJ. Short-Term Heart Rate
Variability: An Independent Predictor of Incident Heart Failure in the Multi-Ethnic Study of
Atherosclerosis (MESA). 50th Cardiovascular Disease Epidemiology and Prevention - and Nutrition, Physical Activity and Metabolism Conference March 2010.
57. Shah S, Herrington D, Howard T, Divers J, Arnett D, Burke G, Kao W, Guo X, Siscovick D,
Chakravarti A, Lima J, Psaty B, Tomaselli G, Rich S, Bowden D, Post W. Use of Principal Component
Analysis Enhances the Ability to Study Associations Between Single Nucleotide Polymorphisms in
NOS1AP and QT Interval in the Multi-Ethnic Study of Atherosclerosis (MESA). 50th Cardiovascular
Disease Epidemiology and Prevention - and - Nutrition, Physical Activity and Metabolism Conference;
March 2010.
58. Twomley K, D'Agostino R, Lawrence J, Melin S, Ellis L, Stacey R, Hamilton C, Torti F, Little W,
Hundley WG. Early and persistent evidence of subclinical cardiovascular injury after receipt of
anthracycline chemotherapy. Circulation122(21 Suppl):A12766 2010.
59. Yeboah J, Herrington D, Bertoni A, Post W, Burke G. Pre-Diabetes and the risk of diabetes
mellitus and cardiovascular events in an adult population: The Multi-Ethnic Study of Atherosclerosis
MESA. . AHA Scientific Session 2010.
60. Agarwal S, Bertoni A, Szklo M, Vaidya D, Post W, Budoff M, Rotter J, Sibley C, Herrington D.
The Prevalence of Metabolic Syndrome and its Components and Incident Cardiovascular Events: Multi
Ethnic Study of Atherosclerosis. Nutrition, Physical Activity and Metabolism and Cardiovascular
Disease Epidemiology and Prevention Scientific Session 2011.
61. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Freedman B, Carr J, Bowden D. Vascular
calcification and prediction of all cause mortality in diabetes: Diabetes Heart Study. American Heart
Association Scientific Sessions 2011.
62. Agarwal S, Cox A, Herrington D, Xu J, Freedman B, Morgan T, Carr J, Bowden D. Coronary
Artery Calcium Score and Prediction of Cardiovascular Mortality in Diabetes. Diabetes Heart Study.
71st American Diabetes Association Scientific Sessions 2011.
63. Agarwal S, Cox A, Herrington D, Xu J, Freedman B, Morgan T, Carr J, Bowden D. Coronary
Artery Calcium and Prediction of Cardiovascular Mortality in Diabetes: Diabetes Heart Study. 23rd
Annual Conference of the Michigan Chapter ACC 2011.
64. Agarwal S, Herrington D, Cox A, Morgan T, Xu J, Carr J, Freedman B, Bowden D. The
Association of Vascular Calcification and All Cause Mortality in Diabetes: Diabetes Heart Study.
AHA Scientific Sessions 2011.
65. Agarwal S, Jacobs D, Vaidya D, Sibley C, Jorgensen N, Rotter J, Chen I, Eng J, Herrington D.
Metabolic Syndrome Derived from Principal Component Analysis and Incident Diabetes: Multi-Ethnic
Study of Atherosclerosis. Nutrition, Physical Activity and Metabolism and Cardiovascular Disease
Epidemiology and Prevention Scientific Session 2011.
66. Balfour P, Bertoni A, Watson K, Choi E, Lima JA, Herrington D. The Association between Amino
Terminal Pro-Brain Natriuretic Peptide and Incident Heart Failure in Diabetes- The Multi Ethnic Study
of Atherosclerosis. AHA Scientific Sessions2011.
67. Jain M, Allem J, Wannenburt T, Henderson R, Rubery B, Upadhya B, Simmons T. Do ICD
implants for primary prevention (PP) meet Center of Medicare Services (CMS) guidelines?: The Wake
Forest Baptist Medical Center experience. AHA Scientific Sessions 2011.
68. Sellers M, Liu Y, Burke G, Divers J, Ouyang P, Palmas W, Post W, Lohman K, Herrington D.
Replication of the Association of PSRC1 and MTHFD1L with Coronary Artery Disease: the
Multi-Ethnic Study of Atherosclerosis. AHA Scientific Sessions2011.
69. Shah SA, Chan C, Kambur T, Tandri H, Brown E, Herrington D, Liu K, Shah SJ. Short-Term
Heart Rate Variability (HRV): An Independent Predictor of Incident Heart Failure (HF) in the
Multi-Ethnic Study of Atherosclerosis. Wake Forest University Resident Research Day 2011.
70. Stacey R, Kock N, D’Agostino R, Torti F, Eckman D, Sane D, Workman S, Lane K, Hundley W.
Doxorubicin Associated Changes in Coronary Artery Histology. J Am Coll Cardiol April
2011;57(Suppl A):A1042011.
71. Yeboah J, Redline S, Johnson C, Tracy R, Ouyang P, Blumenthal RS, Burke GL, Herrington DM.
Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an
adult population: MESA. Atherosclerosis. 2011;219(2):963-8.
72. Agarwal S, Cox A, Herrington D, Jorgensen N, Xu J, Carr J, Freedman B, Bowden D. Calcified
plaque and mortality in diabetes: Diabetes Heart Study. AHA Epidemiology Scientific Sessions 2012.
73. Agarwal S, Cox A, Herrington D, Jorgensen N, Xu J, Carr J, Freedman B, Bowden D. Coronary
calcium, CRP and CVD and all-cause mortality in diabetes: Diabetes Heart Study. AHA
Epidemiology Scientific Sessions 2012.
74. Agarwal S, Calcium supplements and incident CVD events in MESA. AHA Scientific Sessions
Oral Presentation2012.
75. Azeem A, Yeboah J, Soliman EZ, Cox A, Bertoni A, Herrington D, Bowden D. Heart Rate
Corrected QT Interval is an Independent Predictor of All-Cause Mortality in a Diabetic Population –
The Diabetes Heart Study. AHA Scientific Sessions2012.
76. Balfour P. MESA Study: NT-proBNP is a Predictor of Incident HF in Diabetes Mellitus.
CardioSource World News [serial on the Internet]. 2012: Available from: youtube.cswnews.org.
77. Balfour P, A B, Chen H, Chahal H, Lima J, Herrington D. Multiple Biomarkers Predict Risk of
Incident Heart Failure in Population Free of Cardiovascular Disease: The Multi-Ethnic Study of
Atherosclerosis. AHA Scientific Session 2012. Oral.
78. Balfour P, Musani S, Bidulescu A, Washington F, Taylor H, Ramachandran V, Fox E. Biomarkers
Relation to Prevalent Metabolic Syndrome in African Americans: A Multimarker Approach- The
Jackson Heart Study. EPI/NPAM AHA Circulation. 2012; 125: AP033; 2012.
79. Balfour P, Musani S, Williams R, Samdarshi T, Carr J, Hundley G, Terry G, Taylor H,
Ramachandran V, Fox E. Clinical Determinants of Global and Regional Left Ventricular Systolic
Function by Cardiac Magnetic Resonance Imaging: The Jackson Heart Study. AHA Scientific
Sessions 2012. Oral.
80. Chahal H, Bluemke D, McClelland R, Liu K, Balfour P, Herrington D, Shea S, Burke G, Post W,
Shi P, Olson J, Watson K, Folsom A, Lima J. Clinical Determinants of Global and Regional Left
Ventricular Systolic Function by Cardiac Magnetic Resonance Imaging: The Jackson Heart Study.
Poster Presentation. AHA Scientific Sessions, 2012.
81. Dawood F, Judd S, Howard V, Limdi N, Meschia J, Cushman M, Howard G, Herrington D,
Soliman EZ. High Sensitivity C-reactive Protein and the Risk of Stroke in Atrial Fibrillation: The
Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. AHA Scientific
Sessions 2012.
82. Haag J, Morgan T, Robinson K, Stacey R, Thohan V, Vasu S, Hamilton C, Hundley G. Stress MRI
are not Associated with Future Cardiovascular Events in High Risk Patients with Diabetes,
Hypertension, or Pre-Existing Coronary Artery Disease. AHA Scientific Sessions 2012.
83. Jain M, Shah M, Rubery B, Henderson R, Simmons T, editors. Does Physician Review Improve
the Accuracy of NCDR ICD Data Registry?: The Wake Forest Baptist Health Experience. Oral
Presentation at 17th World Congress on Heart Disease 2012
84. Kawel N, Nacif M, Arai A, Gomes A, Hundley W, Johnson C, Prince M, Stacey R, Lima J,
Bluemke D. Trabeculated (non-compacted) and Compact Myocardium in Adults: the Multi-Ethnic
Study of Atherosclerosis. Journal of Cardiovascular Magnetic Resonance 2012;14(Suppl 1):O86 (1
February 2012).
85. Owen A, Samsky M, Patel C, Hernandez A, Jentzer J, Schulte P, Felker GM, Rosenberg PB,
Milano CA, Rogers JG. Outcomes in Extended-Criteria Caradiac Transplantation: A 10-Year
Experience. AHA Scientific Session - Oral Presentation2012.
86. Riley R, Newby K, Don C, Alexander K, Peterson E, Peng A, Gandhi S, Kutcher M, Amsterdam E,
Herrington D. Guideline-Based Treatment of Anemic STEMI Patients: A Report from the ACTION
Registry® - GWTGTM. ACC Scientific Sessions 2012.
87. Riley R, Newby K, Don C, Alexander K, Peterson E, Peng A, Gandhi S, Kutcher M, Amsterdam E,
Herrington D. Guideline-Based Treatment of Anemic STEMI Patients: A Report from the ACTION
Registry® - GWTGTM. Resident and Fellow Research Day, Wake Forest School of Medicine 2012.
88. Riley R, Newby K, Don C, Roe M, Holmes D, Gandhi S, Kutcher M, Herrington D. Timing of
Electrocardiographic Diagnosis in STEMI Patients with an Initial Non-Diagnostic ECG: A Report from
the AHA Mission: Lifeline Program. ACC Scientific Session 2012.
89. Riley R, Newby K, Don C, Roe M, Holmes D, Gandhi S, Kutcher M, Herrington D. Timing of
Electrocardiographic Diagnosis in STEMI Patients with an Initial Non-Diagnostic ECG: A Report from
the AHA Mission: Lifeline Program. Resident and Fellow Research Day, Wake Forest School of
Medicine 2012.
90. Sellers M, Herrington D, Liu Y, Howard T, Hixson J, Shimmin L. Epigenetic Analysis of Lipid
Phenotypes in Liver Tissue from the Pathological Determinants of Atherosclerosis in Youth (PDAY)
Study. AHA Scientific Session 2012.
91. Smith CL, Yeboah J, Sims M, Harman J, Terry G, Crump M, Coherty M, Carr J, Taylor H, editors.
Association of Coronary Calcium Score with Cardiovascular Risk Factors in African Americans: The
Jackson Heart Study (JHS). AHA EPI/NAM scientific session; 2012: Circulation 125: AP154.
92. Stacey R, Andersen M, Hundley G, Thohan V. Comparison of Systolic and Diastolic Criteria for
Isolated Left Ventricular Noncompaction in Cardiac MRI. Journal of Cardiovascular Magnetic
Resonance. 2012;14(Suppl 1):P148 (1 February 2012).
93. Yeboah J, Carr J, Terry G, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff M,
editors. Computer Tomography derived cardiovascular risk markers, incident cardiovascular events and
all- cause mortality in adults free of clinical cardiovascular disease. The Multi Ethnic Study of
Atherosclerosis. Circulation 2012;126: A9536; 2012.
94. Yeboah J, Smith CL, Sims M, Fox E, Ge Y, Terry G, Taylor H, Carr J, editors. Coronary Artery
Calcium Score Improves the Net Reclassification Index of Prevalent Cardiovascular Disease In African
Americans: The Jackson Heart Study. AHA EPI/NAM scientific session; 2012: Circulation AP159.
95. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Carr J, Freedman B, Bowden D. Vascular
calcification and prediction of cardiovascular mortality in diabetes: diabetes heart study. ADA
Scientific Sessions 2012. Poster Presentation.
96. Agarwal S, Cox A, Herrington D, Morgan T, Xu J, Carr J, Freedman B, Bowden D. Vascular
calcification and prediction of cardiovascular mortality in diabetes: diabetes heart study. 24th Annual
Conference of the Michigan Chapter ACC 2012. Poster Presentation.
97. Al-Mallah M, Jurashek S, Whelton S, Ahong Y, Blumenthal R, Nasir K, Schairer J, Alam M,
Quershi W, Blaha M, Keteyian S. Does Cardiorespiratory Fitness Have the Same Prognostic Value in
Men and Women? Data From the FIT Project. . American Heart Association Scientific Sessions
2013.
98. Al-Mallah M, Rubin J, Keteyian S, Alam M, Qureshi W, Schairer J, Nasir K, Blaha M. Racial
Differences in the Prognostic Value of Exercise Capacity: An Analysis of 52,515 Consecutive Patients
From the FIT Project. . American Heart Association Scientific Sessions 2013.
99. Azeem A, Yeboah J, Bertoni A, Burke G, Turkbey E, Szklo M, Herrington D, editors. Association
of Hemoglobin A1C with Cardiovascular Disease and All-Cause Mortality in Individuals without
Diabetes – The Multi-Ethnic Study of Atherosclerosis. Circulation 2013;127(12Suppl): AP278; 2013.
100.Cammarata M, Howard T, Register T, Shea S, Hawkins G, Burke G, Jacobs D, Hoeschele I, Liu
Y, Herrington D. Association of DNA Methylation and Gene Expression of the P2Y12 Receptor: The
Multi-Ethnic Study on Atherosclerosis. AHA Scientific Sessions November 2013.
101.Gibson A, Yeboah J, Arnan M, Sacco R, Balaha M, Szklo M, Herrington D. Coronary Artery
Calcium Score is an Independent Predictor of Incident Stroke in Population Based Adults. Multi-Ethnic
Study of Atherosclerosis (MESA). AHA Scientific Sessions; November 2013.
102.Hall M, Brinkley T, Morgan T, Hamilton C, Jordan J, Stacey R, Chughtai H, Soots S, Little W,
Hundley W. Ectopic fat is associated with gender-specific reducations in left bentricular myocardial
perfusion index during dobutamine stress. AHA Scientific Sessions November 2013.
103.Lakoski S. Cardiorespiratory fitness and risk of cancer incidence and cause-specific mortality
following a cancer diagnosis in men: The Cooper Center longitudinal study. American Society of
Clinical Oncology (ASCO) National Meeting 2013.
104.Lakoski S. Peak Factor Xa Generation As A Candidate Biomarker For Bevacizumab-Induced
Thrombotic and Bleeding Events. Internal Society of Thrombosis and Haemostasis 2013.
105.Lakoski S. Predictors of Factor Xa Generation in Breast Cancer. International Society of
Thrombosis and Haemostasis 2013.
106.Lakoski S. Cardiac Rehabilitation as a Platform to Provide Oncology Rehabilitation. AHA
Scientific Sessions 2013.
107.Lakoski S. Meeting PA Guidelines and Risk of CVD and Cancer Mortality. AHA Scientific
Sessions 2013.
108.Soliman E, Safford M, Muntner P, Khodneva Y, Judd S, Dawood F, Thacker E, Neil Z, Howard
V, Howard G, Herrington D, Cushman M. Atrial Fibrillation is a Risk Factor for Incident Myocardial
Infarction. American College of Cardiology 62nd Annual Scientific Session 2013.
109.Vasu D, Lovato J, Terry J, Taylor H, Fox E, Yeboah J, Correa A, Hundley W, Carr J. Association
of Obesity with Aortic Stiffness in African-American Men and Women: The Jackson Heart Study.
ACC Scientific Sessions2013.
110.Virgadamo S, Azeem A, Yeboah J, Rodriguez C, Cox A, Bowden D, Herrington D, editors.
Premature Ventricular Complexes Predict Mortality in a Population with Type 2 Diabetes – The
Diabetes Heart Study. Circulation 2013;127(12 Suppl):AP049; 2013.
111.Yeboah J, Teixido G, Jacobs D, Terry J, Lima J, Ge Y, Lovato J, Sidney S, Goff D, Carr J.
Comparison or aortic root dimensions using multi-slice computer tomography and 2D transthoracic
echocardiography study. CARDIA Study. AHA Scientific Sessions November 2013.
112.Yeboah J, Terry J, Lovato J, Jacobs D, Ge Y, Sidney S, Lloyd-Jones D, Carr J. Increased
cardiovascular risk is associated with outward remodeling of the thoracic aorta. AHA Scientific
Session November 2013.
113.Anderson J, Sacrinty M, Turner S, Gandhi S, Santos R, Kutcher M, Little W, Applegate R,
editors. Gender Differences in Vascular Complications Associated with Transradial Cardiac
Catheterization and Percutaneous Coronary Intervention: A Single-Center Experience. ACC Scientific
Session; 2013
114.Aggarwal S, Bluemke D, Hundley G, Lima J, Mittleman M, Ouyang P, Parikh N, Vayida D, J Y,
D H, editors. Parity is Associated with Aortic Remodeling: The Multi-Ethnic Study of Atherosclerosis
(MESA). 2014 Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific
Sessions; 2013, Submitted.
115.Alvarez L, Stacey RB, Byrum G, Hundley G, Upadhya B, editors. Utility of Late Gadolinium
Enhancement Cardiac Magnetic Resonance in Troponin Postiive Chest Pain and Unobstructed
Coronary Arteries. Wake Forest School of Medicine Eighth Annual Research Day Poster Presentation,
May 2014.
116.Alvarez L, Stacey RB, Byrum G, Hundley G, Upadhya B. Utility of Late Gadolinium
Enhancement Cardiac Magnetic Resonance in Troponin Postiive Chest Pain and Unobstructed
Coronary Arteries. SCMR Scientific Sessions; New Orleans, LA 2014.
117.Balfour P, Musani S, Williams R, Samdarshi T, Carr J, Hundley F, Terry G, Taylor H, Vasan R,
Fox E, editors. Clinical Determinants of Global Left Ventricular Systolic Function by Cardiac
Magnetic Resonance Imaging: The Jackson Heart Study. Wake Forest School of Medicine Eighth
Annual Research Day Poster Presentation, May 2014.
118.Gomadam P, Stacey RB, Johnsen A, Kitzman D, Kon N, Upadhya B, editors. Cardiac Papillary
Fibroelastoma as a Source of Stroke: A Case Study. Wake Forest School of Medicine Eighth Annual
Research Day Poster Presentation, May 2014.
119.Leigh A, Qureshi W, Swett K, Dharod A, Allison M, Cai J, Gonzalez F, Hurwitz B, Shah S, Desai
A, Spevack D, Rodriguez C. Comparison of Reference Vaulues for Cardiac Structure in Hispanics with
the American Society of Echocardiography Reference Ranges: The Echocardiographic Study of
Latinos (ECHO-SOL). Wake Forest School of Medicine Eighth Annual Research Day Poster
Presentation, May 2014.
120.Milks M, Upadhya B, Hundley G, Stacey R, editors. Right Ventricular Stress-Induced Perfusion
Defects and Late Gadolinium Enhancement in Coronary Artery Disease. Wake Forest School of
Medicine Eighth Annual Research Day Poster Presentation, May 2014.
121.Milks M, Upadhya B, Hundley G, Stacey R. Right Ventricular Stress-Induced Perfusion Defects
and Late Gadolinium Enhancement in Coronary Artery Disease. SCMR Scientific Sessions; New
Orleans, LA 2014.
122.Quershi W. Continuous Positive Airway Pressure Therapy as a Therapy for Cardiac Arrhythmia:
Meta - Analysis of 14 Studies. American Heart Association Scientific Session 2014.
123.Quershi W. Cardiorespiratory Fitness is Associated With Decreased Risk of Incident Atrial
Fibrillation: An Analysis of 66,479 Patients FromThe Henry Ford Hospital Exercise Testing (FIT)
Project. American Heart Association Scientific Sessions 2014.
124.Quershi W. Inverse Relationship Between Inflammation and Cardiorespiratory Fitness: The
Henry Ford Hospital ExercIse Testing Project (FIT Project). American Heart Association Scientific
Session 2014.
125.Qureshi W, Wagenknecht L, Watkins S, Chilton F, Rotter J, Carlos L, Herrington D.
Metabolomic Features Associated with Incident Hypertension – Results from Insulin Resistance
Atherosclerosis Study. AHA Epidemiology and Prevention/Nutrition, Physical Activity and
Metabolism Scientific Sessions 2014.
126.Qureshi W, Wagenknecht L, Watkins S, Chilton F, Rotter J, Carlos L, Herrington D.
Metabolomic Features Associated with Incident Hypertension – Results from Insulin Resistance
Atherosclerosis Study. American Heart Associations Scientific Session Best of EPI/NPAM 2014.
127.Qureshi W, Yeboah J, Bertoni A, Burke G, Herrington D, Foy F. Risk of Incident Hypertension
and Diabetes Mellitus in Habitual Snorers and Sleep Apneic Individuals: The MESA Study. AHA
Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions 2014.
128.Qureshi W, Soliman E, Solomon S, Arking D, Shah A, Shah D, Alonso A, Wagenknecht L,
Herrington D. Traditional Risk Factors for Atrial Fibrillation in Individuals with Normal Left Atrial
Size: The Atherosclerosis Risk in Communities Study. Presentation Abstract. AHA Epidemiology
and Prevention/Nutrition, Physical Activity and Metabolism Scientific Sessions 2014.
129.Stacey R, Meng M, Upadhya B, Rodriguez C, Zhao D, Pu M. Prognosis of Un-Operated Aortic
Stenosis: Risk Stratification by Doppler Echocardiography. American Society of Echocadiography;
Portland, OR 2014.
130.Stacey R, Meng M, Upadhya B, Rodriguez C, Zhao D, Pu M. Effect of Aortic Valve Surgery on
Different Types of Severe Aortic Stenosis Classified by Echocardiography. American Society of
Echocadiography; Portland, OR 2014.
131.Al-Mallah M, Blaha M, Quershi W, Brawner C, Keteyian S, editors. Fitness and Incident
Diabetes: An Analysis of 55,897 Patients from The FIT Project. American College of Cardiology;
March 2014.
132.Al-Mallah M, Qureshi W, Pantelic M, Nour K, editors. Long Term Prognostic Value of Coronary
CT Angiography in Suspected Coronary Artery Disease, A 62 Months Median Follow-Up Study.
American College of Cardiology March 2014.
Electronic Publications:
Sidharth A. Shah, M.D., M.S. Wake Forest Baptist First Hospital in North Carolina to Implant Newly
Approved Device to Treat Heart Failure
http://www.wakehealth.edu/News-Releases/2011/Wake_Forest_Baptist_First_Hospital_in_North_Caro
lina_to_Implant_Newly_Approved_Device_to_Treat_Heart_Failure.htm
Herrington DM, Lakoski S. Chest Pain in Postmenopausal Woman on Hormone Therapy.
Cardiosource Web Site, American College of Cardiology Foundation and Elsevier, Inc. February 2004.
Yeboah J. Cardiovascular Risk Prediction: Two More Studies, Little Progress. Forbes.com, LLC; 2012
[updated 2012; cited August 21, 2012]
http://www.forbes.com/sites/larryhusten/2012/08/21/cardiovascular-risk-prediction-two-more-studies-li
ttle-progress/
Yeboah J.. 2 Tests May Improve Heart Patients' Care, Studies Suggest. US News and World Report,
LP; 2012 [updated 2012; cited August 21, 2012]
http://health.usnews.com/health-news/news/articles/2012/08/21/2-tests-may-improve-heart-patients-car
e-studies-suggest
Yeboah J. Which Heart Risk Test Rates Best? : WebMD, LLC; 2012 [updated 2012; cited August
21, 2012]; http://www.webmd.com/heart/news/20120821/which-heart-risk-test-rated-best
Yeboah J. Predicting Heart Attack Risk: A Calcium Test May Help. Time, Inc.; 2012 [updated 2012;
cited August 22, 2012]
http://healthland.time.com/2012/08/22/predicting-heart-attack-risk-a-calcium-test-may-help/
INVITED COMMENTARY:
Mellen PB, Herrington DM. Estradiol shows no overall effect on blood pressure. First to Know: The
North American Menopause Society. 2005 Dec 15; www.menopause.org/news.html
INVITED PRESENTATIONS:
Dr. Susan Lakoski “Women and Cardiovascular Disease” Wake Forest University School of
Medicine Medical Student Class. August 2003.
Dr. Susan Lakoski “The Association Between Inflammation and Hypertension.” Wake Forest
University School of Medicine Cardiology Research Conference, June 2004
Dr. Phillip Mellen “Cardiovascular Disease and Women” Cardiovascular pathophysiology lecture
series for 2nd year medical students, Wake Forest University, August 2004
Dr. Susan Lakoski “Gender Differences and C-Reactive Protein.” Wake Forest University School of
Medicine Cardiology Research Conference, January 2005
Dr. Susan Lakoski “The Association Between Inflammation and Hypertension.” Cardiovascular
Epidemiology, Biostatistics and Behavioral Medicine Trainee Session, April 2005
Dr. Phillip Mellen “The Metabolic Syndrome, Insulin Resistance, and Coronary Atherosclerotic
Progression” Cardiology Research Conference, Wake Forest University, June 2005
Dr. Phillip Mellen “New Pharmacogenetic Data in Hypertension” Satellite Symposium Invited
Lecture, 14th Annual Scientific Meeting, Quebec Society of Hypertension, Montreal, Quebec, Canada,
January 14, 2006 (sponsored by Bristol-Meyers Squibb Canada and Sanofi-Aventis)
Dr. Phillip Mellen “Whole Grains and Heart Disease” Cardiology Research Conference, Wake Forest
University, May 2006
Dr. Kurt Daniel “Predictors of Poor Epicardial Blood Flow Following PCI” Cardiology Research
Conference, Wake Forest University, May 2006.
Dr. Susan Lakoski “Cardiovascular Risk Assessment in Women” Medicine Cardiology
Research Conference, June 2006.
Dr. Jerry John “Response to Postural Change in Diastolic Heart Failure: Decreased Left Ventricular
Compliance Contributes To Reductions in Stroke Volume and Cardiac Output” Medicine Cardiology
Research Conference, June 2006.
Dr. Susan Lakoski Invited Speaker, AHA Special Session: Improving Cardiovascular Risk
Assessment in Women. “Framingham Risk Score Low Balls Risk in Women.” Nov 2006
Dr. Jerry John “Exercise Intolerance in Diastolic Heart Failure – Evaluation using Cardiopulmonary
Exercise Testing and Echocardiography”, Cardiology Research Conference, Jan 2007.
Dr. Joseph Yeboah “Relationship between Carotid IMT and Brachial Flow-Mediated Dilation in an
Elderly Cohort”, Cardiology Research Conference, Jan 2007.
Dr. Stewart Allen “The association of COX-2 Inhibitors with Endothelial Function”, Cardiology
Research Conference, Jan 2007.
Dr. Darryl Prime “Clinical Utility Of Measures Calculated From The Radial Artery Pulse Pressure
Wave Form” Cardiology Research Conference, Feb 2007.
Dr. Susan Lakoski “Cardiovascular Disease Risk in Women” Wake Forest University School of
Medicine Medical Student Class, Feb 2007.
Dr. Susan Lakoski “Cardiovascular Disease Risk in Women” Winston-Salem Community, June 2007.
Dr. Susan Lakoski Invited Speaker, Cardiovascular Seminar: Novel Risk Factors for Hypertension.
“Inflammation, Blood Pressure, and Risk for Hypertension.” Nov 2007.
Dr. Brandon Stacey “Aortic Stiffness and the Left Ventricle” Cardiology Research Conference, Jan
2008.
Dr. Sidharth Shah “ The Identification and Pathophysiologic Implication of ANG-(1-2) in Human
Cardiovascular Disease States” Cardiology Research Conference, Jan 2008.
Dr. Sidharth Shah”EP Review: Wolff-Parkinson-White (WPW)”. Wake Forest University School of
Medicine Cardiology Fellows’ Conference- October 2008.
Dr. Sidharth Shah “Cardiac Arrest Syndrome”. Wake Forest University School of Medicine
Cardiology Fellows’ Conference-December 2008.
Dr. Manish Jain “Aortic Stiffness: Is it associated with visceral fat and physical activity?”
Cardiology Research Conference, Jan 2009.
Dr. Darryl Prime “The Association between Nitrate Therapy during Acute Myocardial Infarction and
Mortality” Cardiology Research Conference Jan 2009.
Dr. Kurt Daniel “Heart Size by Cardiac CT – A new Epidemiologic (and Clinical?) Tool” Cardiology
Research Conference March 2009.
Dr. Stewart Allen “Propensity Score Analysis of Indices of Thrombosis in Users of Selective and
Non-selective NSAIDs” Cardiology Research Conference March 2009.
Dr. Matthew Belford “Flow Medicated Dilation and Endothelial Derived Proteins”
Cardiology Research Conference May 2009.
Dr. Sidharth Shah “Associations between NOS1AP Genetic Variants and the QT Interval”,
Cardiology Research Conference June 2009.
Dr. Brandon Stacey “Modification of the Effect of Glycemic Status on Aortic Distensibility by Age”,
Cardiology Research Conference June 2009.
Dr. Sidharth Shah “Mitral Stenosis”. Wake Forest University School of Medicine Cardiology
Fellows’ Conference- February 2009.
Dr. Sidharth Shah “Percutaneous Aortic Valve Replacement”. Wake Forest University School of
Medicine Cardiology Fellows’ Conference- April 2009.
Dr. Sidharth Shah Alcohol Septal Ablation”. Wake Forest University School of Medicine Cardiology
Fellows’ Conference-July 2009.
Dr. Sidharth Shah “Current Concepts in Atrial Fibrillation”. Wake Forest University School of
Medicine Cardiology Fellows’ Conference-August 2009.
Dr. Subhashish Agarwal “Metabolic Syndrome & Ethnic Differences: Need for a New Definition”.
Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2010.
Dr. Jennifer Anderson “Omega-3 Fatty Acid/Fish Intake and Brachial Artery Flow-Mediated Dilation
in the Multi-Ethnic Study of Atherosclerosis”. Wake Forest University School of Medicine Cardiology
Fellows’ Conference-January 2010.
Dr. Kurt Daniel “Routine Immediate PCI after Lyutics: A Systemic Review and Meta-Analysis”.
Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2010.
Dr. Jennifer Anderson “Fighting Heart Disease with Food”. Wake Forest University Health
Sciences BestHealth – March 2010.
Dr. Darryl Prime “Relation of Periprocedural Elevated White Blood Cell Count to Stent Thrombosis
after Percutaneous Coronary Intervention for Acute Myocardial Infarction" Wake Forest University
School of Medicine Cardiology Fellows’ Conference-March 2010.
Dr. Brandon Stacey “Glucose, Insulin, and Vascular Stiffness” Wake Forest University School of
Medicine Cardiology Fellows’ Conference-March 2010.
Dr. Pelbreton Balfour “Amino-Terminal pro-BNP, Type 2 Diabetes Mellitus and Incident Heart
Failure” Wake Forest University School of Medicine Cardiology Fellows’ Conference-January 2011.
Dr. Matthew Sellers “Epigenetic and Cardiovascular Disease” Wake Forest University School of
Medicine Cardiology Fellows’ Conference- January 2011.
Dr. Manish Jain “Guidelines based ICD Implantation for Primary Prevention of Sudden Cardiac
Death: WFUBMC Experience” Wake Forest University School of Medicine Cardiology Fellows’
Conference – March 2011.
Dr. Brandon Stacey “Noncompaction of the left ventricle: Cardiac MRI from WFUBMC-Design
and Initial Analysis” – Wake Forest University School of Medicine Cardiology Fellows’ March 2011.
Dr. Mattnew Belford “Flow Mediated Dilation and Endothelial Derived Proteins” Wake Forest
University School of Medicine Cardiology Fellows’ Conference – April 2011.
Dr. Sidharth Shah “Short-term Heart Rate Variability (HRV): A potential Predictor of Incident
Heart Failure in MESA” - Wake Forest University School of Medicine Cardiology Fellows’ –
Conference - April 2011.
Dr. Jennifer Anderson “Sex differences in the relationship of dietary polyunsaturated fatty acids and
cardiovascular disease” - Wake Forest University School of Medicine Cardiology Fellows’ –
Conference - May 2011.
Dr. Amir Azeem “Hemoglobin A1c and Cardiovascular Risk” - - Wake Forest University School of
Medicine Cardiology Fellows’ – Conference -January 2012.
Dr. Robert Riley “Investigating Guideline-Based Care of STEMI Patients. Two Analyses from the
NCDR ACTION Registry-GWTG” - Wake Forest University School of Medicine Cardiology Fellows’
– Conference - February 2012..
Dr. Stewart Allen “Everolimus-eluting stents: The Wake Forest Experience” Cardiology Research
Conference February 2012.
Dr. Sidharth Shah “Genetic Variants in NOS1AP and the QT Interval Across Race/Ethnicty in Adults
Without Cardiovascular Disease” Cardiology Research Conference March 2012.
Dr. Matthew Belford “Flow Mediated Dilation and Endothelial Derived Proteins” Cardiology
Research Conference March 2012.
Dr. Jennifer Anderson “Dietary Long-Chain n-3 Polyunsaturated Fatty Acids and Incident
Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA)” Cardiology Research
Conference April 2012.
Dr. Manish Jain “Does Physician Review Improve the Accuracy of National Cardiovascular Data
Registry (NCDR) ICD Registry Data Submission?” Cardiology Research Conference May 2012.
Dr. Matthew Sellers “Genetics and Cardiovascular Disease” Cardiology Research Conference June
2012.
Dr. Michael Cammarata “Genetic and Epigentic Determinates of Platelet Reactivity” Cardiology
Research Conference January 2013.
Dr. Ashleigh Owen “ Brugada Syndrome, benigh non-ischemis ST elevation, or something in
between? Identification of distinct ST segmanet parameters associated with sudden cardiac death”
Cardiology Research Conference January 2013.
Dr. Farah Dawood “Electrocardiographic Spatial QRS-T Angle and Incident Cardiovascular Disease
in HIN-Infected Patients (from the Strategies for the Management of Antiretroviral Therapy SMART
Study)” Cardiology Research Conference January 2013.
Dr. Robert Riley “The HEART Pathyway Trial and ASAP Cath Study” Cardiology Research
Conference March 2013.
Dr. Amir Azeem “Glycated Hemoglobin and Cardiovascular Risk Assessment in Individuals without
Diabetes Mellitus” Cardiology Research Conference March 2013.
Dr. Pelbreton Balfour “Multiple Biomarkers Predict Risk of Incident Heart Failure in Population Free
of Cardiovascular Disease: MESA” Cardiology Research Conference April 2013.
Dr. Pelbreton Balfour “Clinical Case Conference”, Cardiology MR Imaging Conference, May 2013.
Dr. Matthew Sellers “Replication and Functional Validation of SNPs Previously Associated with
Coronary Artery Disease” Cardiology Research Conference May 2013.
Dr. Manish Jain “Insulation Failure in St. Jude Riata Family Leads: Wake Forest Baptist Health”
Cardiology Research Conference May 2013.
Dr. Jennifer Anderson “Why I Still Love Fish: A Nutrition $ Cardiovascular Disease Update for
2013” Cardiology Research Conference June 2013.
Dr. Ashleigh O. Gibson “Coronary Artery Calcium Score is an Independent Predictor of Incident
Stroke in Population Based Adults. Multi-Ethnic Study of Atherosclerosis (MESA)” Cardiology
Research Conference January 2014.
Dr. Waqas Qureshi “Metabolomics” Cardiology Research Conference January 2014.
Dr. Shivani Aggarwal “Parity and Cardiovascular Disease” Cardiology Research Conference
February 2014.
Dr. Michael Cammarata “Epigenetic Modification and Gene Expression of P2RY12” Cardiology
Research Conference February 2014.
Dr. Joseph Yeboah “Risk Prediction in Primary Cardiovascular Event Prevention” Department of
Internal Medicine Grand Rounds, March 13, 2014.
Dr. Robert Riley “Evaluating Chest Pain in the ED: A Multidisciplinary Paradigm Shift”, Cardiology
Research Conference, April 23, 2014.
Dr. Matthew Belford, “Radial Artery Patency” Cardiology Research Conference Grand Rounds, May
14, 2014.
Dr. Pelbreton Balfour, “Risk Prediction of Incident Heart Failure: Results from the MESA Study”,
Cardiology Research Conference Grand Rounds, May 21, 2014.